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Summary
Summary
The use of  Chromosome Conformation Capture (3C)-derived techniques for  probing 3D
genome structure has shed new light on the principles of genome organization. DNA looping
is  recognized  as  the  major  mechanism  responsible  for  this  organization  in  which
topologically  associated  domains  (TADs)  and  compartments  are  acknowledged  as
hierarchical levels of genome folding at a megabase scale. The cohesin complex, working
together  with  the insulator  protein  CTCF, has shown to  be essential  for  partitioning  the
genome into chromatin loops and TADs.  Cohesin is  a ring-shaped protein complex best
known for its role in sister chromatin cohesion that consists of four subunits: SMC1, SMC3,
RAD21 and SA. In somatic vertebrate cells, the SA subunit can be either SA1 or SA2, thus
giving  rise  to  two  different  cohesin  variants,  cohesin-SA1  and  cohesin-SA2.  Studies  in
human and mouse cells have suggested that these variants have non-redundant functions,
at least regarding cohesion. However, their differential contributions to gene regulation and
genome organization have not been explored.
In order to address this question, we first analysed the genome-wide distribution of the two
cohesin variants in three human cell lines and found that cohesin-SA1 is almost exclusively
present at CTCF-bound sites. In contrast, only a fraction of cohesin-SA2 colocalizes with
cohesin-SA1 and CTCF, while another one occupies non-CTCF positions that are instead
bound  by  transcriptional  regulators.  This  population  is  enriched  at  active  enhancers,  in
particular  at  super-enhancer  elements  responsible  for  establishment  of  cell  identity.
Importantly, cohesin-SA2 can reach CTCF positions in the absence of SA1, but cohesin-SA1
cannot occupy non-CTCF positions when SA2 is absent. Differential affinity of SA1 and SA2
for cohesin-releasing factor WAPL, CTCF and transcriptional regulators may contribute to
the observed differences in the dynamics of their association to chromatin. Downregulation
of cohesin-SA2 has a more pronounced effect on the transcriptome of MCF10A cells and
leads  to  deregulation  of  core  cell-identity  genes.  Using  4C and  Hi-C analyses  we also
explored  the  consequences  of  cohesin  variant  depletion  on  local  and  global  genome
organization.  Our  results  suggest  that  cohesin-SA1 works  together  with  CTCF to define
TADs while cohesin-SA2 facilitates more transient and local regulatory contacts. In summary,
we propose that cohesin-SA2 contributes to cell-type specific gene regulation in a CTCF-
independent fashion, a function that cannot be assumed by cohesin-SA1. Our work provides
a new perspective on understanding the contribution of cohesin mutations to the pathology
of human cancers. 
Resumen
Resumen
El reciente desarrollo  de técnicas de Captura de Conformación Cromosómica (3C) y su
aplicación al estudio de la estructura 3D de la cromatina ha supuesto un gran avance en
nuestro conocimiento de la organización genómica. La formación de "lazos" de DNA es el
principal  mecanismo responsable  de  dicha  organización,  en la  que  los  TADs (dominios
asociados topológicamente) y los compartimentos (A y B) constituyen diferentes niveles de
plegamiento genómico. La cohesina y CTCF son piezas fundamentales en la formación de
estas estructuras. La cohesina es un complejo proteico con forma de anillo, descubierto por
su  papel  en  la  cohesión  de  cromátidas  hermanas.  Está  formado  por  tres  subunidades
comunes,  SMC1, SMC3, RAD21 y una cuarta, la proteína SA, que en vertebrados posee
dos isoformas, SA1 y SA2. De este modo, en las células somáticas coexisten dos variantes
de  cohesina,   cohesina-SA1  y  cohesina-SA2.  Diversos  estudios  en  líneas  celulares  de
mamíferos sugieren que ambos complejos poseen funciones no redundantes, al menos en
relación a su participación en el proceso de cohesión. Quedaba sin embargo por explorar su
contribución a la regulación de la organización genómica y la expresión génica, principal
objetivo de esta Tesis.
El  análisis  de  la  distribución  genómica  de  los  dos  complejos  cohesina  en  tres  líneas
celulares  humanas  ha  revelado  que  mientras  que  la  cohesina-SA1  se  encuentra
exclusivamente en sitios unidos a CTCF, sólo una fracción de la cohesina-SA2 se localiza
en este tipo de posiciones, en tanto que el resto se distribuye en regiones sin CTCF y que
ocupadas en cambio por  reguladores transcripcionales.  Estas regiones se corresponden
principalmente con "enhancers" activos, en particular, "super-enhancers", responsables de
la  transcripción  que  determina  la  identidad  celular.  En  ausencia  de  SA1,  cohesina-SA2
puede seguir ocupando las mismas posiciones con o sin CTCF que ocupa normalmente. Sin
embargo, cohesina-SA1 no puede sustituir  a la cohesina-SA2 en las regiones sin CTCF.
Ambos complejos muestran diferencias tanto en su movilidad como en su estabilidad en la
cromatina,  diferencias que pueden estar  relacionadas con su distinta afinidad por Wapl,
CTCF u otros reguladores transcripcionales. La reducción de los niveles de SA2 tiene un
mayor  impacto  en  la  transcripción,  afectando  a  la  expresión  de  genes  críticos  para  la
identidad celular. El análisis de la contribución específica de cada variante a la organización
genómica mediante Hi-C nos permite concluir que mientras que cohesina-SA1 colabora con
CTCF  en  la  definición  de  los  TADs,  cohesina-SA2  está  implicada  en  la  formación  de
contactos reguladores, locales y transitorios. Por todo ello, proponemos que cohesina-SA2
contribuye a establecer los programas de expresión génica determinantes del tipo celular,
función  que  no  puede  llevar  a  cabo  cohesina-SA1.  Este  trabajo  aporta  una  nueva
perspectiva para entender los posibles mecanismos de patogenicidad de las mutaciones en
cohesina identificadas en cáncer.
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3C: Chromosome Conformation Capture
ADP: Adenosine diphosphate
ATP: Adenosine triphosphate
CdLS: Cornelia de Lange Syndrome
ChIP: Chromatin Immunoprecipitation
ChIP-qPCR: Chromatin Immunoprecipitation followed by quantitative PCR
ChIP-seq:  Chromatin Immunoprecipitation coupled with deep sequencing
CHOPS: C for cognitive impairment and coarse facies, H for heart defects, O for obesity, P
for pulmonary involvement and S for short stature and skeletal dysplasia
co-IP: co-Immunoprecipitation 
CTCF: CCCTC-binding factor
DEG:  Differentially Expressed Gene
dpc: days post coitum
Esco1/2: Establishment of Cohesion 1/2
FACS: Fluorescence activated cell sorting
FISH: Fluorescence In Situ Hybridization
FPKM: fragments per kilobase per million of reads
GSEA: Gene Set Enrichment Analysis 
GWAS: Genome Wide Association Studies
HCAEC: Human Coronary Artery endothelial Cells 
HDAC8: Histone Deacetylase 8
HEAT:  Huntingtin, elongation factor 3 (EF3), protein phosphatase 2A (PP2A), and the yeast
kinase TOR1
HMEC: Human Mammary Epithelial Cells
HUVEC: Human Umbilical Vein endothelial Cells
IFNG: Interferon Gamma
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KO: knockout
MEFs: Mouse Embryonic Fibroblasts
NIPBL: Nipped-B-like protein
NGS: Next Generation Sequencing
n.s.: non significant
Pds5: Precocious dissociation of sisters 5
PP2A: Protein Phosphatase 2A
pre-RC: pre-Replicative Complex
PTM: post-translational modification
RAD21: Double-strand-break repair protein 21 homolog
RNA-seq: RNA-sequencing
RNApolII: RNA polymerase II
RBS: Roberts Syndrome
RT-qPCR: Retrotranscription followed by quantitative PCR
SE: Super-enhancer
SEC: super elongation complex 
Sgo1: Shugoshin 1
siRNA: small interfering RNA
SMC: Structural Maintenance of Chromosomes 
SA: Stromal Antigen (protein)
STAG: Stromal Antigen (gene)
TAD: Topologically Associated Domain
TSS: Transcription Start Site
WAPL: Wings apart-like
WB: Western Blot
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Introduction
1. Genome organization is important for its function
Deciphering the principles of three-dimensional (3D) organization of the genome has always
been a distinctive objective in biology. The size of the DNA poses an incredible challenge to
the cell: almost 2-meter long DNA has to be packed in the 10-m diameter of the human cell
nucleus.  Moreover,  a  single  cell  -the  zygote-  has  to  give  rise  to  a  complex  organism
composed  of  multiple  cell  types,  all  of  them  using  the  same  genetic  information.  The
importance  of  three-dimensional  chromatin  organization  lies  in  providing  a  manageable
chromosome size but also in the fact that folding is not random and contributes to regulate
genome function (Bonev and Cavalli, 2016).
How the genome folds appears to be particularly important for transcription since regulatory
elements, such as enhancers, are often far away from their target genes. Moreover, c is-
regulatory elements occupy a much larger fraction of the genome than the protein coding
genes, with multiple enhancers acting on a single gene. Enhancer–promoter contacts must
be tightly regulated in order to prevent spurious activation of non-target neighboring genes
(de Laat  and Duboule,  2013). 3D chromatin structure transitions have been observed in
development  and  cell  differentiation,  and  are  often  dysregulated  in  disease  processes
(Norton and Phillips-Cremins, 2017).  Structural variations in the human genome such as
deletions, inversions or translocations that alter genome topology have been shown to cause
malformation  syndromes (Lupiañez  et  al.,  2015)  and  to  promote  tumourigenesis  though
oncogene activation (Hnisz  et  al.,  2016).  It  has also  become evident  that  most  disease
associated genomic variants identified in Genome Wide Association Studies (GWAS) are
present in cis-regulatory elements. Indeed, in the current post-GWAS era, a challenging task
is to go beyond traditional exome-sequencing approaches in order to identify non coding
variants  in  enhancers  as  major  candidates  for  functional  interpretation  of  GWAS  loci.
Identification  of  the  gene  whose  altered  expression  promotes  the  disease  requires
understanding of  the contacts in  which the mutated element is engaged (Smemo et  al.,
2014). Clearly, understanding genome architecture is key not only from the perspective of
basic knowledge, but also for human disease.
Chromosomes fold in a hierarchy of structures with increasing complexity (Figure I1). At the
bottom of  the  hierarchy  is  the  nucleosome in  which  147-bp  long stretch  of  DNA wraps
around histone octamers composed of  two copies each of  H2A, H2B, H3,  and H4. The
amino-  and  carboxy-terminal  tails  of  histones  are  subject  to  several  post-translational
modifications (PTMs) such as methylation, acetylation, phosphorylation, sumoylation, ADP-
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ribosylation, or ubiquitinylation (Taverna et al., 2007). Histone modifications determine how
nucleosomes  interact  with  each  other,  control  access  to  given  sequences,  and  recruit
effector proteins that ultimately determine the activity of the region in terms of transcription,
recombination,  etc.  As  we  will  explain  below,  functional  elements  of  the  genome  are
characterized by the presence of certain combination of histone marks. 
For a long time it was thought that the 10-nm chromatin fiber, composed of nucleosomes,
would fold into solenoid-like arrays to form a 30nm chromatin fiber, but the existence of this
entity in vivo is unclear (Fussner et al., 2012). Instead, nucleosomes appear to be arranged
in heterogeneous groups, called 'clutches',  in a cell-type dependent manner (Ricci et al.,
2015). 
Figure I1. Hierarchy of genome organization
Chromosomes fold in a hierarchy of  structures with increasing complexity, from nucleosomal
DNA to  non-random arrangements  of  individual  chromosomes  (territories)  within  the  nuclear
space. Adapted from Bonev and Cavalli, 2016.
On  the  upper  end  of  the  hierarchical  organization  of  genomes  we  find  individual
chromosome territories, as observed by fluorescence in situ hybridization (FISH, Cremer and
Cremer, 2001). Between the chromatin fiber and the chromosome territories, genome folding
has  been  a  black  box for  many  years.  A large  number  of  contributions  in  the  last  two
decades have driven dramatic and rapid advances in the field of 3D genome structure and
have provided a better insight into the link between spatial organization of genome and its
function. Our current view of genome organization is based largely on data obtained with two
experimental approaches: FISH to visualize directly the proximity between two or more DNA
segments in individual cells and chromosome conformation capture (3C) and its derivatives,
which assess contact frequencies between selected genomic sites in cell populations. I will
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briefly review these methodologies in section 1.1 before continuing with the description of
the higher levels of chromatin organization in section 1.2.
1.1.Techniques for probing genome organization 
The development of Chromosome Conformation Capture (3C) and its derived methods to
probe genomic contacts between distant loci has been a major breakthrough in the field of
genome organization (Dekker et al., 2002; de Wit and de Laat, 2012). This technique relies
on the idea that digestion and re-ligation of fixed chromatin in cells, followed by quantification
of the ligation junctions, reveals DNA contact frequencies and thereby provides insight into
chromosome topology (Figure I2). 
Figure I2. Chromosome Conformation Capture (3C) technologies
All protocols of Chromosome Conformation Capture (3C) involve a formaldehyde cross-linking
step followed by an enzymatic digestion and a ligation step. Each method uses then different
approaches to generate genomic libraries: secondary digestion for 3C-qPCR, circularization and
inverse PCR for the 4C, “carbon copy” amplification for the 5C and biotinylation and purification
on streptavidin beads for Hi-C. Ligation products are quantified by real-time qPCR in the first
method or by high-throughput sequencing in the others. Adapted from Ea et al., 2015.
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The original 3C technique was based on PCR detection of specific pair of fragments and it
was  therefore  limited  to  detection  of  interactions  between loci  for  which  some previous
knowledge existed. High-throughput versions of 3C, including “4C”, “5C” and “Hi-C”, along
with  the  concomitant  development  of  next-generation  sequencing  (NGS)  technologies,
allowed  for  generation  of  high-resolution  maps  of  genome-wide  contacts.  Libraries  are
generated from millions of cells and thus represent a complex mixture of ligation events that
reflect the average interaction profile of each fragment in the population across the whole
genome.  Single-cell  Hi-C  approaches  have  been  recently  developed  and  reveal  the
stochastic nature of the genome folding (Flyamer et al., 2017).
Even though every 3C-derived technique has its application depending on the biological
question that should be answered, Hi-C is the technique of choice for taking an insight into
genome-wide interaction  profiles  (Liberman-Aiden et  al.,  2009).  In  the  Hi-C protocol  the
restriction ends are filled with biotinylated nucleotides before ligation. Following sonication,
affinity purification on streptavidin beads ensures that only ligation junctions are selected for
further analysis, greatly reducing the complexity of the mixture to be sequenced. Reads are
mapped to the genome, and when a pair is found on two different restriction fragments, this
is scored as an interaction between these two fragments.  From this,  a matrix of  ligation
frequencies between all fragments in the genome is generated. With increased sequencing
depth, higher resolution can be achieved in the contact maps, although a 10-fold increase in
resolution requires a 100-fold increase in sequence depth.
To look at selected loci in the genome at high resolution, the 4C technique can be used
(Simmonis et al., 2006). In this case, a viewpoint is set in the region of interest and all the
contacts of this fragment with the rest of the genome are detected. In 4C, the ligated 3C
template is subject to a second restriction digest and ligation to generate small DNA circles,
some of which will contain the 3C ligation junctions. Inverse PCR using viewpoint-specific
primers is then used to amplify all sequences contacting this chromosomal site, which are
then analyzed by NGS methods. We previously used 4C-seq to probe the architecture of two
regions of the mouse genome in embryonic brains and adult pancreas (Cuadrado et al.,
2015). 
Apart from the application in 3C-derived assays, NGS technologies are used with Chromatin
Immunoprecipitation  (ChIP-seq)  to  generate  genome-wide  binding  maps  of  DNA-binding
proteins as well as genome-wide epigenomic profiles (Barski et al., 2007; Mikkelsen et al.,
2007).  Covalent  histone  modifications  together  with  DNA  methylation  constitute  the
epigenome of the cell (Kouzarides, 2007). A number of consortia have used ChIP-seq as a
12
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tool to provide a panel of histone modifications for each cell type in order to gain an insight
into  cell-type  specific  epigenomes  (https://www.cell.com/consortium/IHEC?code=cell-site).
This initiative has generated a large amount of data for which development of integrative
computational approaches was necessary to capture the patterns of histone modifications
and translate them into biologically  meaningful  genomic features called chromatin states
(Ernst et al., 2011). Two popular tools are ChromHMM and Segway. In both approaches, the
ChIP-seq  experiments  are  transformed  into  genome-wide  multivariate  signals  and
subsequently used as observed variables in a probabilistic inference algorithm (Mammana
and Chung, 2015).
In addition to 3C and NGS methods, the field of genome organization has benefited from the
development of super-resolution microscopy (Boettiger et al., 2016; Fabre et al., 2015; Wani
et al.,  2016) as well as from the application of polymer and statistical physics models to
simulate genome organization. These simulations can, based on the existing data coming
from 3C-derived assays, predict  future experiments or can work in the opposite direction
and,  based  on  simple  biological  assumptions,  deliver  output  that  can  be  compared  to
existing Hi-C contact maps (Haddad et al., 2017; Bianco et al., 2017). 
Combination of outlined techniques led to paradigm shift in the understanding of function
and higher-order organization of interphase genome, more specifically at scales of 10-100s
of  kilobases  in  size,  corresponding  to  organizational  levels  between  nucleosomes  and
chromosome territories. 
1.2. Shedding light into the black box: from chromatin loops to compartments 
Hi-C experiments revealed that the genome is divided into sub-chromosomal compartments
named “A” and “B” (Lieberman-Aiden et al., 2009). Compartments represent accumulation of
large  (several  Mb)  chromosomal  domains  which  are  usually  located  on  the  same
chromosome,  giving  rise  to  “plaid”  pattern  visible  on  genome-wide  interaction  matrices
obtained  from  Hi-C.  They  reflect  tendency  for  regions  of  similar  chromatin  status  and
epigenomic  type  to  be  in  a  close  proximity,  separated  from  loci  of  opposite  features
(Lieberman-Aiden  et  al.,  2009;  Zhang  et  al.,  2012).  Active,  gene-rich  and  DNAse  I
hypersensitive loci are preferentially clustered in A compartments whereas transcriptionally
silent, gene-poor and DNAse I insensitive loci are converging to form B compartments. Due
to  their  similarity,  it  is  plausible  that  lamina-associated  domains  (LADs)  and  nucleolus-
associated domains (NADs) are actually B-like accumulations of loci at nuclear lamina and
nucleoli (Gibcus and Dekker, 2013) (Figures I1 and I3).
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Figure I3. Chromatin domain folding at different scales
Chromosome territories can be split into A and B compartments, transcriptionally more active or
inactive,  respectively. The  A/B  compartments  are  organized in  superdomains,  which  include
mostly  domains  belonging  to  the  same  chromatin  type.  Superdomains  group  together
topologically associated domains (TADs) of similar chromatin type. Inside TADs, loop formation is
favored,  in  particular  between  enhancers  and  promoters.  A number  of  proteins  previously
characterized as insulators show high enrichment between TADs and/or at the base of the loops.
Loops  are  formed  by  the  combined  action  of  loop  extrusion  factors  (SMC complexes)  and
boundary factors (such as CTCF) (Taken from Pueschel et al., 2016).
Subsequent Hi-C and 5C experiments reported the existence of smaller contact domains
within larger A and B compartments named TADs for “topologically associated domain” (Nora
et al.,  2012; Dixon et al.,  2012; Sexton et al.,  2012). These sub-megabase domains are
defined as  regions with high propensity  to  self-interact,  partially  insulated from adjacent
TADs. In other words, long-range interactions between loci within the same domain occur
with higher frequency than interactions between loci located in adjacent domains (Figures I1
and I3).
Strikingly, genes  within  the same TAD tend to  have  similar  gene  expression  dynamics,
suggesting the role of these domains in coordinating the activity of a group of genes (Gibcus
and  Dekker,  2013).  Since  their  discovery,  TADs  have  been  recognized  as  functional
regulatory blocks of genome that prevent erroneous interactions between gene promoters
and regulatory elements, restricting contacts to occur between promoters and enhancers
within  the  same  TAD  (Nora  et  al.,  2012;  Hughes  et  al.,  2014;  Mifsud  et  al.,  2015;
Schoenfelder et al., 2015). Accordingly, deletion of a boundary between two TADs allows for
erroneous  interactions  leading  to  aberrant  gene  expression  due  to  non-physiological
contacts  between  genes  and  enhancers  from  adjacent  TADs  (Flavahan  et  al.,  2016;
Lupiáñez et al., 2015; Guo et al., 2015; Franke et al., 2016). TADs demonstrate remarkable
structural conservation across cell-types and even species (Dixon et al., 2015; Lonfat et al.,
14
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2014;  Le Dily  et  al.,  2014;  Jin  et  al.,  2013;  Dixon et  al.,  2012)  in  contrast  to  A and  B
compartments, which are largely cell-type specific. Moreover, TADs also display epigenomic
uniformity in active or inactive marks (Rao et al., 2014; Sexton et al., 2012; Le Dily et al.,
2014).  Experimental  data  revealed  that  TAD borders  are  enriched  in  different  features:
transcription start sites, different chromatin states and different chromatin-binding proteins,
namely architectural protein CTCF and cohesin, hinting to an important role of both proteins
in TAD formation and maintenance (Rao et al., 2014; Dixon et al., 2012; Sexton et al., 2012;
Nora et al., 2012; Fraser et al., 2015). 
Apart from compartments and TADs, a study employing very high resolution Hi-C identified
chromatin loops as another sub-chromosomal structure visible as prominent “corner peaks”
on  Hi-C  contact  maps  (Rao  et  al.,  2014).  Loops  arise  when  two  loci  on  the  same
chromosome are strongly linked together frequently forming a contact domain, an interval of
DNA in which all loci pairs between loop anchors interact more frequently with each other
than random pairs of loci at similar distances on the linear DNA. The finding of loops gives
support to the idea of correlation between chromatin loops and gene regulation by showing
that the anchors of cell-type specific loops are often promoters of differentially expressed
genes. Interestingly, the loop anchors contain binding sites for CTCF and cohesin. Indeed,
many TADs are recognized as loop domains indicating strong contact between CTCF- and
cohesin-bound loop anchors (Rao et al., 2017). 
The hierarchy of chromatin organization as described in Figure I1 has been recently called
into question. Acute depletion of cohesin or CTCF erases chromatin loops and eliminates
TADs, while compartments are strengthened (Gassler et al., 2017; Nora et al., 2017; Rao et
al., 2017; Wutz et al., 2017; Schwarzer et al., 2017). These results suggest that TADs and
compartments  are  two  distinct  levels  of  genome  organization  established  by  different
mechanisms. 
2. Cohesin as a key element for genome organization
As explained  in  the  previous  section,  CTCF and  cohesin  are  major  players  in  genome
organization.  CTCF is  a  DNA binding  protein  with  eleven  zinc-finger  domains  that  was
identified as a transcriptional regulator of the c-myc oncogene (Lobanenkov et al., 1990).
Since then it has been in many functions related to gene regulation (reviewed by Ong and
Corces, 2014). CTCF is the main insulator protein described in vertebrates and as such has
the  ability  to  interfere  with  enhancer-promoter  communication  or  establish  functional
domains of gene expression (Yusufzai et al., 2004). It is highly conserved among eukaryotes
15
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with the notable exceptions of yeast, D. melanogaster and C. elegans. CTCF binds tens of
thousands of sites along mammalian genomes, recognizing a non-palindromic motif (Kim et
al.,  2007). In this section, I review in detail current knowledge on cohesin. 
2.1. Composition and mode of action of cohesin
Cohesin belongs to the  Structural  Maintenance of  Chromosome  (SMC) family  of  protein
complexes present in eukaryotes. Condensin and the SMC5/6 complex are also members of
this  family  of  chromosomal organizers (Jeppsson et  al.,  2014).  Cohesin is composed of
SMC1 and SMC3, the kleisin RAD21 and the HEAT repeat  containing SA subunit.  SMC
proteins are long polypeptides (1,000-1,300 amino acids) that consist of two long coiled-coil
segments connected by a globular and flexible hinge domain. SMC monomers fold back on
themselves at the hinge and establish anti-parallel interactions of the two coiled-coil regions
to bring together the N- and C-terminal domains of the protein to create a globular head
domain (Figure I4). 
Figure I4. The cohesin complex form a ring
The folding of SMC proteins at the hinge domain brings two termini of the protein together to
create the ATPase head domain. Head domains of SMC1 and SMC3 are connected through
RAD21, which is in turn bound by the SA subunit. White arrows show electron micrographs of the
human  cohesin  complex  purified  from  HeLa  cells.  Electron  microscopy  images  taken  from
Anderson et al., 2002.
Monomers  of  SMC1  and  SMC3  associate  tightly  with  each  other  through  their  hinges
whereas their head domains are connected by RAD21 and can also engage and interact
with each other to form an ABC-like ATPase with two ATP binding pockets. The SA subunit
associates to the middle region of RAD21. As we will discuss in detail in Section 4, somatic
vertebrate cells express two versions of the SA subunit, SA1 and SA2. Additional versions of
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all subunits except SMC3 are also present in germ cells.  The complex  purified from cell
extracts or assembled from recombinant protein has a ring shape, as  shown by electron
microscopy (Anderson et al., 2002; Huis in ’t Veld et al., 2014).
Cohesin subunits were first identified in budding yeast through genetic screens for mutants
that  led  to  premature  separation  of  sister  chromatids  in  mitosis  (Guacci  et  al.,  1997;
Michaelis  et  al.,  1997).  Four  of  these  proteins  were  soon  after  shown  to  be  part  of  a
holocomplex  present  in  Xenopus  egg  extracts  and  human  cells  that  was  essential  to
maintain sister chromatid cohesion (Losada et al., 1998; Losada et al., 2000; Sumara et al.,
2000). 
It had initially been thought that cohesin might promote cohesion through direct interaction
with sister chromatids established through ATPase heads of SMC1 and SMC3 (Nasmyth et
al., 2000; Losada and Hirano, 2001). However, the finding that SMC1, SMC3 and RAD21
proteins associate to each other creating a tripartite ring (Haering et al., 2002) together with
the observation of ring-shaped complexes in electron micrographs (Anderson et al., 2002)
led  Kim  Nasmyth  and  colleagues  to  propose  that  cohesin  might  embrace  DNA fibers
topologically (Gruber et al., 2003). Several biochemical experiments have since supported
the  idea  of  cohesin  entrapping  the  two  sister  chromatids  within  the  lumen  of  the  ring
(Haering et al., 2008). One version of this embrace (ring) model holds that a single cohesin
ring entraps the two sister chromatids between the SMC coiled coils (Figure I5, left). Another
possibility, known as “two gates” model, is that one DNA molecule is held between the coiled
coils whereas the second one is kept in the pocket created between the flexible central
region of RAD21 and the engaged head domains of SMC1 and SMC3 (Figure I5, middle). A
third  model  suggests  that  two  cohesin  rings,  each  holding  a  sister  chromatid  associate
through their SA subunits (Zhang et al., 2008) (Figure I5, right). 
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Figure I5. Current models of cohesin association to DNA. 
The cohesin ring binds to DNA topologically, holding the chromatin fibers inside its lumen. In the
"embrace model", the two sister chromatids are held between the coiled coils whereas the “two
gates” model suggests that one sister is held between the coiled coils and the other is located
within  the  pocket  created  by  flexible  central  region  of  SCC1  and  the  engaged  SMC  head
domains. The “handcuff” model assumes proposes that two cohesin complexes each embracing
a sister chromatid interact possibly through their SA subunit.
2.2. Association of cohesin with chromatin is dynamic
The association of cohesin with chromatin throughout the cell cycle is tightly regulated and
highly dynamic. Cohesin loading occurs early in G1 and is facilitated by the heterodimer of
NIPBL and  MAU2,  which  promotes  ATP hydrolysis  at  the  SMC heads  and  causes  the
dissociation of the hinge domains creating an “entry gate” for the DNA fiber (Arumugan et al
2003; Gruber et al., 2006). In vitro, cohesin can bind DNA topologically even in the absence
of the loader, although rather inefficiently (Murayama and Uhlmann, 2014). NIPBL is a hook-
shaped protein with several HEAT repeats that is sufficient to stimulate in vitro loading of
cohesin on DNA (Chao et al.,  2017; Kikuchi et al., 2016) while MAU2 may function as a
chromatin adaptor (Chao et al., 2015).
After loading, two other HEAT repeat domain-containing proteins associate with cohesin to
modulate its association with chromatin, Pds5 and WAPL. Together, they promote cohesin
unloading (Gandhi et al., 2006; Tedeschi et al., 2013; Ouyang et al., 2016) (Figure I6). This
process requires dissociation of the interface between the SMC3 head domain and the N
terminus of the kleisin subunit, called “exit gate” (Gligoris et al., 2014; Huis In’t Veld et al.,
2014; Buheitel and Stemmann, 2013).
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Figure I6. Dynamic association of cohesin to chromatin. 
Loading of cohesin is facilitated by the heterodimer NIPBL-MAU2. Association of Pds5-WAPL
with chromatin-bound cohesin promotes cohesin unloading. 
During  DNA  replication,  a  fraction  of  cohesin,  presumably  co-entrapping  the  sister
chromatids, becomes stably bound to chromatin (Gerlich et al., 2006). This process requires
acetylation of two conserved Lysines (K105 and K108) in the head domain of the SMC3 by
acetyltransferases Esco1  and Esco2.  Cohesin  acetylation  is  accompanied  by  binding  of
Sororin  to  cohesin  through  Pds5,  which  displaces  WAPL and  counteracts  its  unloading
activity  (Nishiyama  et  al.,  2010).  When  cells  enter  mitosis  cohesin  dissociates  from
chromatin in two steps. More than 90% of cohesin is removed from chromatin in prophase
when Sororin  dissociation  restores  WAPL activity  and  allows  opening  of  the  “exit  gate”
(Losada et al., 2002; Shintomi and Hirano, 2010; Nishiyama et al., 2013). A small fraction of
cohesin,  enriched around  centromeres,  is  protected from dissociation  by  a  factor  called
Shugoshin 1 (Sgo1) and its partner the protein phosphatase 2A (PP2A) (Liu et al., 2013).
This fraction secures proper chromosome alignment and is removed in anaphase to allow
the segregation of the sister chromatids to daughter cells (Waizenegger et al., 2000). In the
telophase-early G1 cohesin is loaded again on chromatin, after deacetylation of SMC3 by
HDAC8 (Deardorff et al., 2012). 
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2.3. Cohesion-independent roles of cohesin
As explained above,  cohesin was identified and named after  its  role in  sister  chromatid
cohesion. Cohesion promotes homologous recombination-mediated repair of double-strand
breaks during S and G2 phases.  In  mitosis,  cohesion prevents premature separation of
sister  chromatids  until  all  chromosomes  are  aligned  in  the  metaphase  plate  with  sister
kinetochores attached to opposite spindle poles (Nasmyth and Haering, 2009; Morales and
Losada, 2018). Intriguingly, proper cohesion can be maintained with a small fraction of the
cohesin complexes present in the cell (Heidinger-Pauli et al., 2010). In addition, cohesin is
loaded on chromatin in G1, way before it is required for establishing cohesion, and is present
in  non-proliferating  cells.  These  facts  suggested  that  cohesin  could  have  other  roles  in
addition to holding the sister chromatids together.  
One of the first  evidences for cohesion-independent roles of cohesin came from work in
Drosophila when mutants for Nipped-B, the ortholog of NIPBL, were found to be deficient in
activation of Homeobox genes (Rollins et al., 1999; Rollins et al., 2004). Moreover, cohesin
ablation  or  cleavage  in  Drosophila  postmitotic  neurons  affected  axon  pruning  through
downregulation  of  the  Ecdysone  receptor  (Pauli  et  al.,  2008;  Schuldiner  et  al.,  2008).
Cohesin-dependent gene regulation of the Runx1 transcription factor was also reported in
zebrafish (Horsfield et al.,  2007). 
A clear breakthrough in the field came with the analyses of cohesin distribution along human
and  mouse  genomes  by  chromatin  immunoprecipitation,  which  revealed  an  extensive
colocalization of cohesin with CTCF (Parelho et al., 2008; Wendt et al., 2008). Early work on
CTCF recognized this  chromatin binding protein  as an insulator  for  its  ability  to  provide
insulation of promoters from distant enhancers at the H19-IGF2 locus, a process important
for  proper  expression  of  these  imprinted  genes (Bell  and  Felsenfeld,  2000;  Hark  et  al.,
2000). 3C experiments elucidated that CTCF exerts its function by creating allele-specific
chromatin loops (Kurukuti  et  al.,  2006; Splinter et al.,  2006). Strikingly, it  was found that
cohesin  was indispensable  for  CTCF to fulfill  its  enhancer-blocking activity  at  H19-IGF2
locus (Wendt et al., 2008) as well as in the chicken Beta-globin locus (Parelho et al., 2008).
CTCF  was  dispensable  for  cohesin  loading  to  chromatin,  but  it  was  required  for  its
recruitment to specific loci (Wendt et al., 2008).
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Figure I7. Cohesin organizes interphase chromatin through looping 
Cohesin can tether two distant genomic loci in-cis promoting long-range genomic interactions.
Together with CTCF, Mediator complex and other TFs, cohesin mediates loops between genes
and regulatory elements. Moreover, cohesin-mediated loops can regulate transcription of gene
clusters and organize replication factories (not depicted). 
The ability of cohesin to bring together two DNA molecules in  trans, the sister chromatids,
sparked the idea that  cohesin could also generate chromatin loops by bringing together
distant  genomic  loci  of  one  chromatid,  i.e. in  cis,  that  could  control  enhancer–promoter
interactions topologically, maybe together with CTCF (Figure I7).  Evidence supporting this
hypothesis came from 3C studies showing that cohesin mediates long-range chromosomal
cis-interactions at the developmentally regulated cytokine locus IFNG (Hadjur et al., 2009).
Cohesin  and  CTCF were  also  reported  to  regulate  gene  expression  through  chromatin
looping in gene clusters such as the human apolipoprotein gene cluster (Mishiro et al., 2009)
and protocadherin-alpha gene cluster (Monahan et al., 2012). Additional results using HiC
and  4C analyses  showed  the  importance  of  cohesin-CTCF  for  chromatin  contacts  and
overall chromosome organization (Sofueva et al., 2013; Zuin et al., 2014)
Cohesin  can  also  function  in  genome  organization  and  gene  regulation  in  a  CTCF-
independent  manner.  Analysis  of  cohesin  distribution  in  liver  and  breast  cancer  cells
revealed a fraction of cohesin positions lacking CTCF that were instead bound by tissue
specific transcription factors (Schmidt et al., 2010). Likewise, cohesin was shown to occupy
the promoters of pluripotency genes in mouse embryonic stem cells together with Mediator
and NIPBL and to mediate contacts with the corresponding enhancers to promote high gene
expression levels (Kagey et al., 2010).  
Genome topology is also important for processes other than transcriptional regulation. In
preparation for DNA replication, neighboring origins of replications cluster together to form
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replication factories through chromatin looping (Jackson and Pombo, 1998; Lemaitre et al.,
2005).  Cohesin  was  found  to  interact  with  the  components  of  pre-RC  (pre-replication
complex)  to  spatially  organize  these  replication  factories  enabling  efficient  origin  firing
(Guillou  et  al.,  2010).  Cohesin  also  participates  in  DNA  looping  required  for  locus
rearrangement  at  the  Immunoglobulin  and T cell  receptor  loci  in  B and T lymphocytes,
respectively (Degner et al., 2011; Seitan et al., 2011).
2.4. Genome-wide distribution of cohesin: implications for genome organization
The first published genome wide map of cohesin distribution in a metazoan organism came
from Drosophila (Misulovin et al., 2008). It showed a complete colocalization of cohesin with
its  loader  (Nipped-B),  peaking  at  transcription  start  sites  of  active  genes.  In  mammals,
however, only a small fraction of cohesin positions was found at the same sites as the loader
(Zuin et al., 2014) whereas, as explained above, the overlap with CTCF was very extensive
(Wendt et al., 2008; Parelho et al., 2008). From these data, it was not clear whether the
overlap of  cohesin with CTCF was the consequence of  cohesin being loaded at  CTCF-
bound locations or the ability of cohesin to move laterally after binding DNA topologically as
it  had been previously  suggested from experiments in  yeast  (Hu et  al.,  2011;  Ocampo-
Hafalla and Uhlmann, 2011). 
Consistent with the latter possibility, lateral movement of cohesin complexes along DNA by
passive  diffusion  has  been  recently  observed  in  vitro  using  single  molecule  imaging
(Davidson et al.,  2016; Stigler et al., 2016). DNA-bound cohesin acquires a conformation
that reduces the size of the central pore of the complex thus hindering its ability to diffuse
freely past different DNA-bound obstacles, such as CTCF.  How well these assays reflect
cohesin dynamics in vivo is uncertain as they are performed on naked DNA and do not
require  ATP or  the  cohesin  loader.  A third  study  showed cohesin  complexes  loaded  by
NIPBL-MAU2 and moving along DNA in an ATP-dependent manner (Kanke et al.,  2016).
Addition of WAPL-Pds5 reduced translocation while acetylation promoted it. The underlying
reason for these effects remains unclear, although it could be related with conformational
changes in the ring affecting its ATPase activity. 
Movement  of  cohesin  in  vivo  is  inferred  from its  distribution,  assessed by  ChIP-seq.  In
mouse fibroblasts lacking CTCF, cohesin accumulation at CTCF sites was reduced and the
complex appeared instead at the transcription start sites of active genes, where NIPBL was
also  found  and  where  loading  possibly  occurred.  Co-depletion  of  CTCF  and  WAPL to
prevent cohesin unloading led to cohesin accumulation in broad peaks at 3′-ends of active
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genes, in particular if these converge on each other, but not when transcription was switched
off (Busslinger et al., 2017). These results suggest that transcriptional machinery can push
cohesin in mammalian cells, as previously reported in yeast (Lengronne et al., 2004; Glynn
et al., 2004). In vitro, motor proteins can also push cohesin along DNA (Stigler et al., 2016).
Some evidences also suggest  that  cohesin can be pushed by the replication machinery
(Kanke et al., 2016). 
2.5. The loop extrusion model
In addition to this passive movement, current evidence support an active translocation of
cohesin  along  DNA  or,  more  exactly,  active  reeling  of  DNA  through  cohesin.  It  was
hypothesized several years ago that SMC complex could act by catching a small loop that
would then be processively enlarged by the sliding of the complex down the base of the loop
(Nasmyth, 2001). 
Chromatin loops predominantly form between convergent CTCF sites, and such orientation
is  required  for  looping  (de  Wit  et  al.,  2015;  Guo  et  al.,  2015;  Sanborn  et  al.,  2015),
suggesting  a  linear  scanning mechanism that  recognizes  the  orientation  of  CTCF sites.
Based on polymer simulations, two groups proposed that genome organization as observed
by Hi-C could  be modeled  with  cis-acting  loop-extruding  factors,  likely  cohesin,  forming
progressively larger loops until being stopped by boundary proteins, like CTCF (Sanborn et
al., 2015; Fudenberg et al., 2016). Very recent work has now provided experimental support
for this loop-extrusion model (Figure I8).  For instance, a prediction of the model is that the
longer the extruding complex stays bound to DNA, the longer the loops should be. Indeed,
depletion of WAPL or Pds5 to prevent cohesin unloading increases loop length genome wide
(Haarhuis et al., 2017; Wutz et al., 2017). How cohesin recognizes the directionality of CTCF
is currently unknown. It is also unclear if a single complex or two tethered complexes are
responsible  for  the  extruding.  Importantly,  in  recent  in  vitro  experiments  using  purified
condensin showed that a single complex performs loop extrusion: it reeled one side of the
DNA loop while the other end remained stably bound (Ganji et al., 2018). 
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Figure I8. Cohesin as a loop extrusion factor
The  loop  extrusion  model  for  genome organization  helps  to  explain  how  certain  regions  of
chromosomes stay close together and why cohesin rings are often found coinciding with CTCF,
which binds to specific DNA sequences. Adapted from Dolgin, 2017.
3. Cohesin mutations in human disease
The  fact  that  cohesin  plays  major  roles  in  chromosome  segregation  and  genome
organization makes it rather difficult to understand the pathological consequences of cohesin
defects. In the germline, mutations in cohesin genes and its regulators are responsible for
developmental abnormalities collectively called cohesinopathies. Mutations in cohesin have
also been identified in many different cancer types.
3.1. Cohesin mutations in cohesinopathies
Most  common  cohesinopathies  are  Cornelia  de  Lange  syndrome  (CdLS)  and  Roberts
Syndrome (RBS),  a multisystemic  disorders  with a  broad clinical  spectrum that  includes
cognitive impairment, growth retardation, craniofacial abnormalities, limb defects, deafness
and heart defects among others (Banerji et al., 2017a).
CdLS affects up to 1:10,000 newborns. This autosomal dominant disorder is caused in 65%
of the cases by mutations in NIPBL gene, while mutations in SMC1, SMC3, RAD21, and
HDAC8 account for around 10% of diagnosed patients. Cells from these patients do not
display obvious cohesion defects, and instead altered transcriptional profiles are observed
(Liu et al.,  2009). Studies using zebrafish and mouse models revealed several pathways
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crucial  for  embryonic  development,  such  as  the  HOX genes  that  might  be  affected  by
cohesin insufficiency while defects in cohesion were not found (Remeseiro et al., 2013). In
NIPBL heterozygous  mice  the  protocadherin  genes  (PCDH),  clusters  of  genes  that  are
expressed  in  an  exclusive  manner  to  provide  neuronal  identity,  were  found  to  be
misregulated (Kawauchi et al., 2009) and subsequent studies showed that cohesin-mediated
DNA looping is involved in PCDH promoter choice (Guo et al., 2012; Cuadrado et al., 2015)
indicating how cohesin insufficiencies might affect the developing brain. 
Recently, a new genetic disorder was discovered, the CHOPS syndrome  (C for cognitive
impairment  and  coarse  facies,  H  for  heart  defects,  O  for  obesity,  P  for  pulmonary
involvement and S for short stature and skeletal dysplasia) that shares striking similarities
with CdLS in terms of transcriptional profiles (Izumi et al.,  2015). It  arises due to gain-of
function mutation in the gene coding for AFF4, a subunit of super elongation complex (SEC)
responsible for mobilization of paused RNA polymerase II (RNA pol II). These mutations led
to aberrant genome-wide distribution of both AFF4 and cohesin around TSS of upregulated
genes. Interestingly, similar alterations in the behavior of AFF4 and cohesin were observed
in CdLS, pointing to a similar mechanism of pathogenesis in both syndromes related with the
role of cohesin in transcriptional regulation.
RBS is caused by homozygous mutations in the gene for Esco2, one of the two cohesin
acetyltransferases present in vertebrate cells (Vega et al., 2005). Unlike CdLS, cells from
RBS patients exhibit a spectrum of cohesion aberrations: chromosomal segregation defects,
premature  centromere  separation,  aneuploidy,  lagging  chromosomes  and  reduced
proliferation.  Esco2  appears  to  be  particularly  important  for  cohesion  establishment  in
pericentric heterochromatin (Whelan et al., 2012). Therefore, the proposed model for RBS
holds that the phenotype is due to mitotic failure and loss of progenitor stem cells through
apoptosis.
3.2. Cohesin mutations in human malignancies
Cohesin had first  been associated to cancer when mutations in genes encoding cohesin
subunits  were linked  to  genome instability  observed  in  colorectal  cancer  (Barber  et  al.,
2008).  A few years  later,  mutations  in  STAG2 gene  were  found  in  glioblastoma,  Ewing
sarcoma and melanoma (Solomon et al., 2011). More importantly, this study also hinted to
chromosome mis-segregation as the consequence of cohesin dysfunction. Recently, pan-
cancer  studies  identified  recurrent  somatic  mutations  in  the  genes  encoding  cohesin
subunits  and cohesin  regulator  proteins  across many cancer  types,  recognizing cohesin
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network as one of the most frequently mutated in cancer (Kandoth et al., 2013; Lawrence et
al., 2013; Leiserson et al., 2015; Martincorena et al., 2017) (Figure I9). Contrary to the initial
studies mentioned above, more recent data indicate that in the majority of tumours or cancer
cell lines analyzed there is no clear correlation between the presence of cohesin mutations
and aneuploidy. Thus, cohesion is unlikely to be the function impaired in these tumour cells.
Instead, lower cohesin dosage could affect differentiation or alter gene expression.
Sequencing  efforts  in  acute  myeloid  leukemia  (AML)  samples  and  other  myeloid
malignancies identified mutations in cohesin related genes in more than 10% of the tumours
(Welch et al.,  2012; Yoshida et al.,  2011; The Cancer Genome Atlas Research Network,
2013). These mutations were found to be largely nonsense (70%) or frame-shift (17%) with
no obvious hotspots, suggesting the molecular loss of function as the probable consequence
(Kon  et  al.,  2013;  Thol  et  al.,  2014).  Even  in  the  absence  of  cohesin  mutations,  low
expression  of  cohesin  components  was  detected  in  a  significant  fraction  of  myeloid
malignancies (Thota et al., 2014). Clonal analysis showed that cohesin mutations are early
events  and suggested that  mutations  are present  in  the dominant  clone,  but  not  in  the
founder  one  (Jan  et  al.,  2012;  Thol  et  al.,  2014).  These  results  indicate  that  cohesin
mutations provide a specific genetic context for the acquisition of the “second hit” or promote
transformation to more aggressive disease. 
Figure I9. Cohesin mutations in cancer
Data were obtained from the cBioPortal  for  Cancer  Genomics.  Only  mutations  in  the genes
encoding  cohesin  subunits  are shown.  Additional  mutations  are found in  cohesin regulators.
Adapted from De Koninck and Losada, 2016.
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Importantly, cohesin mutations in myeloid malignancies were not associated with aberrant
karyotypes (Thota et al., 2014). To better understand the contribution of cohesin mutations to
tumorigenesis,  functional  studies  were  performed  using  transgenic  mouse  models  and
shRNA knockdown (Mazumdar et al., 2015; Mullenders et al., 2015; Viny et al., 2015). These
studies consistently demonstrated that cohesin mutation or loss led to in-vivo and in-vitro
expansion  of  hematopoietic  stem  cells  (HSC),  impaired  differentiation  and  skewing  of
transcriptional  program  towards  HSC  signature.  Moreover,  changes  in  chromatin
accessibility were also observed in regions enriched in DNA-binding motifs of transcription
factors involved in  the maintenance of  the HSC stem-cell  programme (Mazumdar et  al.,
2015; Mullenders et al., 2015; Viny et al., 2015; Wilson et al., 2010; Fisher et al., 2017).
Importantly, even when cohesin dosage was drastically reduced, sister chromatid cohesion
seemed to be fine, as previously reported in yeast (Heidinger-Pauli et al., 2010). Thus, these
studies suggested that reduced cohesin activity promotes transformation through delaying
lineage commitment while favoring activation of stem cell transcriptional programs, and that
this could be achieved through alteration of chromatin accessibility of stemness associated
TFs. However, it is unclear whether the observed changes in gene expression and chromatin
accessibility are cause or consequence of the observed increase in self-renewal and the
reduced differentiation.
Cohesin  mutations  are  also  common  in  urothelial  bladder  cancer.  While  other  cohesin
subunits were found mutated at low rates (2-6%), the mutation rate of  STAG2,  the gene
encoding SA2,  was substantially  higher (16%) (Balbás-Martínez et  al.,  2013;  Guo et  al.,
2013; Solomon et al., 2013; Taylor et al., 2014).  STAG2 loss in low-grade, non-aggressive
tumors was associated to better prognosis, whereas the opposite was observed for more
aggressive tumors. Again, no clear link between STAG2 loss and aberrant karyotypes could
be found. The same is true for Ewing sarcoma, a pediatric tumor of the bone and soft tissues
in which STAG2 mutations are also very frequent (Brohl et al. 2014; Crompton et al. 2014;
Tirode et al. 2014). 
Finally, whole-genome sequencing data from more than 200 samples of colorectal cancer
(CRC) patients together with ChIP-seq analyses in a CRC cell line revealed a high incidence
of  mutations  in  cohesin/CTCF binding sites  in  the  non-coding  genome (Katainen et  al.,
2015).  A fraction of  these mutations are predicted to affect  CTCF binding affinity to cis-
regulatory  elements  and  could  therefore  contribute  to  tumourigenesis  through  aberrant
expression  of  their  target  genes.  Another  epigenetic  mechanism  recently  described  in
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gliomas  involves  disruption  of  boundary  elements  through  hypermethylation  of
CTCF/cohesin binding sites leading to oncogene activation (Flavahan et al., 2016). 
4. Two versions of cohesin in somatic cells with non redundant functions
Somatic  vertebrate  cells  contain  two versions  of  the  cohesin  complex  that  carry  SMC1,
SMC3, RAD21 and either SA1 or SA2 (Losada et al., 2000; Sumara et al., 2000). Initially,
cohesin-SA2 was shown to be at  least  3 times more abundant than SA1 in human and
Xenopus somatic cells,  while this ratio was reversed in extracts prepared from Xenopus
oocytes.  Thus,  the relative  abundance of  the two variant  complexes could be regulated
during development or according to cell types (Losada et al., 2000). The functional specificity
of the two variant cohesin complexes remains unclear and is one of the main goals of the
current Thesis. 
Both SA1 and SA2 proteins are more than 1250 amino acids long and are characterized by
the presence of 17 HEAT (Huntingtin, elongation factor 3 (EF3), protein phosphatase 2A
(PP2A), and the yeast kinase TOR1) repeats in the central region (Hara et al., 2014). They
share high sequence homology along the central region, but differ in their C and N terminal
regions (Figure I10). Current evidence suggests that the interaction between cohesin and
CTCF overlaps largely with SA motif and is found to be nearly perfectly conserved between
two paralogs (Xiao et al., 2011) 
Figure I10. Schematic representation of SA proteins and their domains 
The percentages refer to sequence identity between two proteins in the corresponding regions
(N-terminal, central and C-terminal regions). Modified from Pezic et al., 2017). 
The crystal structure of SA2 bound to the central flexible regions of RAD21 was recently
reported (Hara et al., 2014). It revealed an extensive interface between SA2 and RAD21,
which shows high conservation between SA1 and SA2. The study further identified a region
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from aa 250 to aa 330 to which cohesin regulators WAPL and Sgo1 bind in a mutually
exclusive manner, providing a molecular mechanisms for centromeric cohesin protection by
Sgo1 in  mitosis.  However, the  crystal  structure  does  not  contain  the  N and  C terminal
regions that are less conserved between the two SA proteins. 
In spite of their high sequence similarity and their similar chromatin-association dynamics
throughout the cell-cycle, cohesin-SA1 and cohesin-SA2 have non-redundant functions. The
best evidence for this assertion is that mouse deficient for SA1 or SA2 are embryonic lethal
(Remeseiro et al., 2012a; M. De Koninck and E. Lapi, unpublished results). Analysis of SA1
deficient mouse embryo fibroblasts (MEFs) revealed a more pronounced role of cohesin-
SA1 in telomeric cohesion while cohesin-SA2 appeared to be more important for cohesion at
centromeres.  Depletion of SA1 and SA2 using siRNA in HeLa cells had reached similar
conclusions (Canudas and Smith, 2009). SA1 contains an AT-hook domain, absent in SA2,
shown to be essential for the association of SA1 with telomeric DNA (Bisht et al., 2013; red
square in Figure I10) and interacts with the telomere binding protein TRF1 (Canudas et al.,
2007). Telomere cohesion is relevant to allow efficient replication of telomeres and in the
absence of SA1 replication defects lead to chromosome segregation defects and increased
aneuploidy  compared  with  wild  type  MEFs  (Remeseiro  et  al.,  2012a).  Despite  the
preferential  roles  of  cohesin-SA1  and  cohesin-SA2  in  mediating  cohesion  at  different
chromosome regions,  any of the two complexes provide sufficient cohesion to allow cell
proliferation, at least in cultured cells (van der Lelij et al., 2017).  
SA1  deficient  murine  embryos  died  by  12.5  dpc  although  some  exceptional  embryos
reached  later  stages  of  development.  These  embryos  displayed  severe  developmental
abnormalities at the organismal level as well as gene expression changes at the cellular
level (Remeseiro et al., 2012b). Moreover, mapping cohesin distribution in wild type and SA1
KO MEFs revealed that  cohesin-SA2 repositions to new sites with reduced overlap with
CTCF  in  the  absence  of  cohesin-SA1.  We  speculate  that  these  changes  in  cohesin
distribution likely contribute to alter gene expression.
Co-immunoprecipitation of cohesin-SA1 but not cohesin-SA2 with RNA polymerase II (RNA
pol II) and components of the superelongation complex (SEC) from HeLa cell lysates has
been reported (Izumi et al., 2014). This complex is responsible for mobilization of the paused
RNA pol II machinery and thereby regulates transcriptional elongation. Results in Drosophila
also suggested a role for cohesin in promoting the transition promoter-proximal paused RNA
polII  to  elongation  at  many genes although  in  this  organism a single  SA subunit  exists
(Schaaf et al., 2013). As mentioned before, mutations in components of the SEC complex
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have  been  identified  in  CHOPS syndrome,  a  disorder that  phenotypically  overlaps  with
Cornelia de Lange syndrome (CdLS). It is therefore possible that some of the transcriptional
alterations observed in SA1 deficient cells result from altered regulation of transcriptional
elongation.
Reduced dosage of SA1 in adult animals results in increased susceptibility to spontaneous
cancer,  in  particular  pancreatic  cancer  (Remeseiro  et  al.,  2012a).  Interestingly,  reduced
dosage of SA1 altered the architecture of the Regenerating islet-derived (Reg) gene cluster
in the pancreas of adult mice, as probed by 4C-seq analyses, and decreased the expression
of Reg genes (Cuadrado et al., 2015). Given the role of Reg proteins in inflammation, and
the  known impact  of  inflammation  in  pancreatic  cancer  development,  we  proposed  that
downregulation of Reg gene expression could be responsible for the increased incidence of
pancreatic cancer observed SA1 heterozygous mice. 
As reviewed in the previous section, loss of function mutations in the  STAG2 gene have
been identified in several human cancers most prominently bladder cancer, Ewing sarcoma
and acute myeloid leukaemia (De Koninck and Losada, 2016). Genomic instability was not
observed in these tumours, which suggested that loss of cohesin-SA2 likely contributes to
tumourigenesis through altered gene regulation. Functional studies in hematopoietic stem
cell precursors support this idea (Viny et al., 2015; Viny et al., 2018). Complete elimination of
cohesin is lethal for the cell while the presence of either cohesin variant is sufficient to allow
proliferation  of  tissue  culture  cells  (van  der  Lelij  et  al.,  2017),  but  not  during  embryo
development.  We  speculate  that  cohesin-SA1  can  carry  out  the  essential  functions  of
cohesin related with sister chromatid cohesion in STAG2-deficient cancer cells while it may
not  be  able  to  fully  compensate  for  the  loss  of  cohesin-SA2,  thereby  promoting
tumourigenesis through gene deregulation. 
Little is known about the potential functional specificities of cohesin-SA1 and cohesin-SA2 in
genome organization and gene regulation. Addressing this question is the main aim of this
Thesis.
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Objectives
1. Analyse the genome-wide distribution of cohesin-SA1 and cohesin-SA2
as  well  as  their  association  to  functional  genomic  elements  in  non
tumoral human cell lines.
2. Evaluate  the  stability  and  dynamics  of  association  to  chromatin  of
cohesin-SA1 and cohesin-SA2.
3. Assess the impact of cohesin-SA1 and cohesin-SA2 downregulation on
the transcriptome.
4. Study the specific contributions of cohesin-SA1 and cohesin-SA2 to 3D
genome organization. 
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Cell lines. Human primary cell lines were purchased from Lonza and cultured according to
the  manufacturer's  recommendations.  NHA (Normal  Human  Astrocytes,  CC-2565)  were
grown in ABM basal medium (CC-3187) supplemented with AGM Bulletkit (CC-4123); SKMC
(Skeletal  Muscle  Cells,  CC-2561)  were  cultured  in  SkBM  basal  medium  (CC-3161)
supplemented with SkGM Bulletkit (CC-4139); NHBE (Normal Human Bronchial Epithelial
Cells, CC-2540) were cultured in BEBM basal medium (CC-3171) supplemented with BEGM
Bulletkit  (CC-4175); HCAEC (Coronary Artery Endothelial Cells,  CC-2585) were grown in
EBM2  basal  medium  (CC-3156)  supplemented  EGM2-MV  Bulletkit  (CC-4147);  NHEK
(Normal  Human  Epidermal  Keratinocytes,  #00192627)  were  grown  in  KBM-Gold  basal
medium (#00192151) supplemented with KGM-Gold Bulletkit (#00192060). HMEC (Normal
Mammary  Epithelial  Cells,  CC-2551)  were  cultured  in  MEBM  basal  medium  (CC-3171)
supplemented with MEGM Bulletkit  (CC-3150).  NHOst (Normal  Human Osteoblasts,  CC-
2538) were grown in OBM basal medium (CC-3208) supplemented with OGM Bulletkit (CC-
3207). PrEC (Prostate Epithelial Cells, CC-2555) were cultured with PrEBM basal medium
(CC-3165) supplemented with PrEGM Bulletkit (CC-3166). HUVEC (Human Umbilical Vein
Endothelial Cells,  CC-2517) were grown in EBM basal medium (CC-3121) supplemented
with EGM Bulletkit (CC-3124). MCF10A cells (a gift from M. Quintela, CNIO) were grown in
DMEM/F12  (#31330038,  Thermofisher)  supplemented  with  20ng/ml  of  EGF,  0.5mg/ml
hydrocortisone, 100ng/ml of cholera toxin, 10mg/ml of insulin and 5% of horse serum. 
Antibodies. A rabbit polyclonal antibody recognizing human WAPL was generated using a
recombinant C-terminal fragment of the protein (352 amino acids long) obtained by PCR
amplification of  full  length hWAPL cDNA [a gift  from T. Hirano (RIKEN, Japan)].   Rabbit
polyclonal antibodies against SA1, SA2, SMC1 and RAD21 were generated using synthetic
peptides  as  immunogens  [SA1-C  (CEDDSGFGMPMF),  SA2  (CDPASIMDESVLGVSMF),
SMC1  (CDLTKYPDANPNPNEQ),  RAD21,  GGDQDQEERRWNKRTQQMLC]  and  affinity
purified.  Rabbit  polyclonal  antibody  against  ZMYM2  was  generated  using  a  ZMYM2
fragment (residues 923–1377) as immunogen [a gift from H. Yu (UT Southwestern, US)].
Commercial antibodies were CTCF (07-729, Millipore), tubulin (DM1A, Sigma), histone H3
(Abcam AB1791).
Quantitative immunoblotting in whole cell extracts and chromatin fractions. Cells were
collected  by  trypsinization,  counted,  resuspended  in  SDS-PAGE  loading  buffer  at  107
cells/ml, sonicated and boiled. Equal volumes were separated by SDS-PAGE and analyzed
by immunoblotting. For chromatin fractionation we followed the protocol from (Méndez and
Stillman, 2000).  To isolate chromatin, cells were resuspended (4 × 107 cells/ml) in buffer A
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(10 mM HEPES, [pH 7.9], 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol, 1 mM
DTT, 5 μg of aprotinin per ml, 5 μg of leupeptin per ml, 0.5 μg of pepstatin A per ml 0.1 mM
phenylmethylsulfonyl fluoride). Triton X-100 (0.1%) was added, and the cells were incubated
for 5 min on ice. Nuclei were collected in pellet 1 (P1) by low-speed centrifugation (4 min,
1,300 ×  g, 4°C). Nuclei were washed once in buffer A, and then lysed in buffer B (3 mM
EDTA, 0.2 mM EGTA, 1 mM DTT, protease inhibitors as described above) 30 min on ice.
Insoluble chromatin was collected by centrifugation (4 min, 1,700 × g, 4°C), washed once in
buffer  B,  and  centrifuged  again  under  the  same  conditions.  Chromatin  pellet  was
resuspended in Laemmli buffer and sonicated for 15 s at 20% amplitude. Fractions were run
on SDS gels alongside increasing amounts of recombinant  proteins corresponding to C-
terminal fragments of human SA1 and SA2 to estimate the amount of each variant subunit.
To assess the strength of  chromatin association of  cohesin variants,  chromatin fractions
were treated with modified buffer A (10mM HEPES, 1.5mM MgCl2,  0.34M sucrose, 10%
glycerol, 1mM DTT and protease inhibitors) containing 0.25 or 0.5M NaCl for 10, 20 or 30
min on ice.  Solubilized proteins  were separated from insoluble  chromatin  by  low speed
centrifugation (4 min at 1,700 x g) and the latter analyzed by immunoblotting.
Immunoprecipitation. Whole cell extracts from MCF10A cells were prepared by lysis on ice
for  30 min  in  TBS supplemented with 0.5% NP-40,  0.5mM DTT, 0.1mM PMSF and 1X
complete protease inhibitor cocktail (Roche) followed by sonication. NaCl was added to 0.3M
and the extract  rotated  for  30  min  at  4ºC.  After  centrifugation,  the  soluble  fraction  was
recovered and diluted to bring the extract back to 0.1M NaCl and 10% glycerol was added.
Antibodies  were cross-linked to protein  A Pureproteome magnetic  beads (Millipore)  at  1
mg/ml (SA1, SA2 and IgG as control)  and incubated with extracts overnight at 4ºC. The
beads were washed 6 times with 20 vol of lysis buffer and anlaysed by LC-MS/MS. 
LC-MS/MS Analysis. Proteins from antibody beads were eluted in two consecutive steps in
2 vol of elution buffer (8M urea, 100mM Tris-HCl pH 8) by shaking for 10 min. Samples were
digested by standard Filter Aided Sample Preparation (FASP). Proteins were reduced with
10mM DTT, alkylated with 50mM IAA for 20 min in the dark and digested with 1:50 Lys-C
(Wako) for 4 h. Samples were diluted in 50mM ammonium bicarbonate and digested with
1:100 Trypsin (Promega) overnight at 37ºC. Resulting peptides were desalted using a Sep-
Pak C18 cartridge for  SPE (Waters Corp.),  vacuum-dried and resuspended in 0.5% FA.
Immunoprecipitates  were analysed using a  nanoLC Ultra system (Eksigent,  Dublin,  CA)
coupled with a LTQ-Orbitrap Velos instrument (Thermo) via nanoESI (ProxeonBiosystem,
Waltham, MA). Two technical replicates were performed. Raw data were analysed using
MaxQuant1.5.3.30  with  Andromeda as  the  search  engine  against  UniProtKB/Swiss-Prot
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(20,584 sequences). Peptides were filtered at 1% FDR. For protein assessment (FDR <1%),
at  least  one unique peptide was required for  both identification and quantification.  Other
parameters were set as default. The resulting “proteingroup.txt” file was loaded in Perseus
(v1.5.1.6). Missing values were imputed from a normal distribution. A two-sample Student’s
T-Test  (one  side)  was  used  corrected  for  multiple  testing  using  a  permutation-based
approach. 
siRNA.  MCF10A cells  were transfected with 50 nM onTARGETplus SMARTpool siRNAs
(Dharmacon L-010638, L-021351, L-006833 and L-020165 for SA1, SA2, SMC1 and CTCF,
respectively) using DharmaFECT reagent 1. Transfection efficiency was first estimated by
qRT-PCR 24 h after transfection, and typically reached more than 90% downregulation (data
not shown). Cells were taken at 72h and protein levels assessed by immunoblot.
ChIP sequencing and analysis. Chromatin immunoprecipitation (ChIP) was performed as
described (D’Alessio et al., 2015), with some modifications. Confluent cells were cross-linked
with  1% formaldehyde  added  to  the  media  for  15  minutes  at  RT. After  quenching  with
0.125M  Glycine,  fixed  cells  were  washed  twice  with  PBS  containing  1mM  PMSF  and
protease inhibitors, pelleted and lysed in lysis buffer (1%SDS, 10mM EDTA, 50mM Tris-HCl
pH 8.1)  at  2x107 cells/ml.  107 cells  equivalent  to  40-50 mg of  chromatin were used per
immunoprecipitation  reaction  with  25  mg  of  antibody.  Sonication  was  performed  with  a
Covaris system (shearing time 30 min, 20% duty cycle, intensity 6, 200 cycles per burst and
30 s per cycle) in a minimum volume of 2 ml. For calibrated ChIP-seq in siC, siSA1 and
siSA2-treated MCF10A cells,  20% of  chromatin  from mouse ES cells  was added to the
human chromatin. The calibrated ChiP-seq was performed in order to correct the technical
variability between replicates and obtain quantitative information about  occupancy of  the
same antibody among samples from different  conditions (Figure MM1).  We doubled the
amount  of  antibody used for  the immunoprecipitations in  order  to reduce differences on
antibody saturation among conditions. ChIP-seq profiles for each antibody were multiplied by
the occupancy ratio (OR) = (WmIPh)/(WhIPm),  where Wh and IPh are the number of reads
mapped to the human genome from input (W) and immunoprecipitated fractions (IP) and Wm
and IPm are reads mapped to the mouse genome from input and IP fractions  (Hu et al.,
2015). 
39
Materials and Methods
Figure MM1. Calibrated  ChIP-seq read distribution around common positions defined in
mouse ES cells
Calibrated ChIP-seq allows for quantitative comparison of protein binding between samples of
different conditions. It  uses “calibration” sample as an internal control to correct for technical
noise. Note the experimental variability of the two replicates for SA2 in SA2-depleted cells. 
From  6  to  10ng  of  immunoprecipitated  chromatin  (as  quantitated  by  fluorometry)  were
electrophoresed on an agarose gel and independent sample-specific fractions of 100–200
bp were taken. Adapter-ligated library was completed by limited-cycle PCR with Illumina PE
primers (11 to 13 cycles).  DNA libraries were applied to an Illumina flow cell  for  cluster
generation and sequenced on the Illumina Genome Analyzer IIx (GAIIx). Image analysis was
performed with Illumina Real Time Analysis software (RTA1.8). 
Alignment of 50-bp (76-bp for calibrated ChIP samples) long sequences to the reference
genome  (GRCh37/hg19,  February  2009)  was  performed  using  'BWA'  (Li  and  Durbin,
2009) or 'Bowtie2' (Langmead and Salzberg, 2012) under default settings. Duplicates were
removed using Picardtools (version 1.60) and peak calling was carried out using MACS2
(version 2.1.1.20160309)  setting  a  q  value (FDR) to 0.05 or  0.01 (SMC1,  SA1,  SA2 in
HMEC) and using the '--extsize' argument with the values obtained in the MACS2 'predictd'
step (Zhang et al., 2008). All comparisons used the input tracks as "control", and each one of
the datasets as "treatment". 
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Common, SA1-only and SA2-only positions were defined using BEDtools v2.26 (Quinlan and
Hall, 2010)with a minimum of 1 nt overlap. Common positions were defined in two steps: 1)
overlap between SMC1 and SA1 bed files was performed using '-wa -wb' argument and the
positions  obtained  were  concatenated  and  sorted  using  'cat'  and  'sort  -k1,1  -k2,2n'
commands. The output was merged using 'bedtools merge' function and considered as one
dataset;  2)  this was overlapped with the SA2 dataset  as above. SA1-only and SA2-only
positions are those where SA1 or SA2 do not overlap among each other.
Mean  read  density  profiles and  read  density  heatmaps  for  different  chromatin  binding
proteins  were  generated  with  deepTools  2.0 (Ramírez  et  al.,  2016) usam BAM  files  of
processed reads and plotting them around peak summits of SA1 or SA2 only or common
positions.  
For Motif discovery analysis, whole sequences of cohesin positions were extracted and used
for  motif  enrichment  analysis  using MEME-ChIP from MEME Suite  (Bailey  et  al.,  2009).
Default  parameters  were  used  except  for  the  following  ones:  -ccut  0,  -meme-mod  anr,
-meme-minw:  6,  -meme-maxw:  50,  -nmeme:  600,  -meme-nmotifs:  10,  -meme-maxsize:
200,000. 
Enrichment of cohesin positions (SA1 and SA2-only and common) at HMEC and HCAEC
chromatin states (Ernst et al., 2011)   was defined using 'intersect' function from BEDtools
utilities (v2.26) with a minimum of 1nt overlap. The analysis was performed making sure that
one position does not belong to two different chromatin states.
To analyse cohesin distribution along super-enhancers, ChIP-seq reads from SA1 and SA2
in  HMECs  and  HCAECs  were  plotted  along  HMEC  super-enhancers (Whyte  et  al.,
2013) using the "scale-regions" parameter from deepTools to adjust all the super-enhancers
to a predefined size and applying a local regression (LOESS) to smooth the read signals. 
ChIP-qPCR and Re-ChIP.  ChIP-qPCR on immunoprecipitated chromatin  was performed
using the SYBR Green PCR Master Mix and an ABI Prism® 7900HT instrument (Applied
Biosystems®).  Primers  were  designed  using  OligoPerfect  Designer™  (Invitrogen)  and
reactions were performed in triplicate. Chromosome coordinates of the validated peaks and
the corresponding primers are listed in Supplementary Table 7. The relative amount of each
amplified fragment was normalized with respect to the amplification obtained from input DNA
using the ΔΔCt method and represented as indicated in the corresponding figure legends.
ReChIP experiment was performed with the Re-ChIP-IT kit (#53016, Active Motif) according
to the manufacturer's protocol.  Briefly, MCF10A cells were fixed, lysed and sonicated as
described in the ChIP protocol. Fifty ug of chromatin were incubated with 20 ug of the first
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antibody (SA1, SA2 or IgG) in presence of  magnetic  beads,  washed,  eluted and further
incubated with 5 ug of the second antibody (SA1, SA2, SMC1 or IgG). Eluted chromatin was
analyzed by quantitative PCR. 1 ng of immunoprecipitated chromatin from two conditions,
SA2 ChIP followed by IgG ReChIP and SA2 ChIP followed by SA1 ReChIP, was used to
prepare  libraries  for  Re-ChIP sequencing.  Libraries  were  prepared  with  18  PCR cycles.
Peaks were called in SA2-SA1 ReChIP  upon normalization with SA2-IgG ReChIP signals.
Quantitative RT-PCR (RT-qPCR) and RNA-sequencing (RNA-seq). cDNAs were prepared
using the Superscript II reverse transcriptase (Invitrogen) from total RNA (RNeasy Mini Kit,
Qiagen) and RT-qPCR analyses were performed using the SYBR Green PCR Master Mix
and an ABI  Prism® 7900HT instrument  (Applied  Biosystems®).  Primers (Supplementary
Table  7)  were  designed  using  OligoPerfect  Designer™  (Invitrogen).  Reactions  were
performed in triplicate. Quantifications were normalized to endogenous GAPDH, using the
ΔΔCt method.
For  RNA-seq  libraries  (three  replicates  for  condition),  polyA+RNA was  purified  with  the
Dynabeads  mRNA purification  kit  (Invitrogen)  from  DNaseI-treated  total  RNA,  randomly
fragmented, converted to cDNA and processed through subsequent enzymatic treatments of
end-repair,  dA-tailing,  and  ligation  to  adapters  as  in  Illumina's  "TruSeq  RNA  Sample
Preparation  Guide"  (Part  #  15008136 Rev. A).  Adapter-ligated library was completed by
limited-cycle PCR with Illumina PE primers (8 cycles). The resulting purified cDNA library
was applied to an Illumina flow cell for cluster generation (TruSeq cluster generation kit v5)
and sequenced on the Genome Analyzer IIx with SBS TruSeq v5 reagents by following
manufacturer's protocols. Fastq files with 50-nt single-end sequenced reads were quality-
checked  with  FastQC (S.  Andrews,
http://www.bioinformatics.babraham.ac.uk/projects/fastqc/)  and  aligned  to  the  human
genome  (GRCh37/hg19)  with  Nextpresso  (http://bioinfo.cnio.es/nextpresso/)  executing
TopHat-2.0.0 using Bowtie 0.12.7 and Samtools 0.1.16 allowing two mismatches and five
multi-hits. Transcript assembly, estimation of their abundances and differential expression
were calculated with  Cufflinks  1.3.0  using the human genome annotation  data  set  from
Ensembl.  To account  for  multiple  hypotheses testing,  the estimated significance level  (p
value) was adjusted using Benjamini-Hochberg False Discovery Rate (FDR) correction. For
differential expression, FDR<0.05, log2fold change<-0.5 or >0.5 and fpkm>3 in at least one
of the two conditions compared was required.
GSEAPreranked was used to perform a gene set enrichment analysis  (Subramanian et al.,
2007).  We  used  the  RNA-seq  gene  list  ranked  by  statistic,  setting  ‘gene  set’  as  the
permutation method and we run it with 1000 permutations. 
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Hi-C.  HiC was performed as described in  (Rao et  al.,  2014)  for  in-situ  HiC,  with some
modifications.  Briefly:  Cell  preparation and cross-linking:  2-5 million  of  MCF10A cells
were grown under above mentioned culture conditions and were arrested in G1 by means of
high confluence (150,000 cells per cm2). Cells were washed with PBS and a solution of 1%
formaldehyde in serum-free medium was added directly to the plate. After 10 minutes of
incubation at room temperature, glycine was added to a final concentration of 0.125 M to
quench the formaldehyde and stop the cross-linking reaction. Cells were incubated for 5
minutes at room temperature and then put on ice for at least 15 minutes. Cells were washed
with PBS and harvested in PBS using a scrapper.  Restriction enzyme digestion step was
performed using MboI enzyme. Two library replicates per condition were sequenced (>200
million read pairs each.  Data were processed using TADbit (Serra et  al.,  2017) for  read
quality  control,  read  mapping,  interaction  detection,  interaction  filtering,  and  matrix
normalization.  First,  the  reads  were  checked  using  an  implemented  FastQC protocol  in
TADbit. This allowed discarding problematic samples and detect systematic artifacts. Then, a
fragment-based  strategy  in  TADbit  was  used  for  mapping  the  remaining  reads  to  the
reference human genome (GRCh38). The mapping strategy resulted in about 80% of reads
mapped uniquely to the genome. Next, non-informative contacts between two reads were
filtered, including self-circles, dangling-ends, errors, random breaks or duplicates. The final
interaction matrices resulted in 272 to 303 millions of  valid interactions per experimental
condition.  These valid  interactions  were then used  to  generate  genome-wide interaction
maps at 100 Kb and 40 Kb to segment the genome into the so-called A/B compartments,
Topologically Associating Domains (TADs), and produce differential interaction maps. 
A/B compartments were calculated using vanilla normalized and decay corrected matrices
as  implemented  in  TADbit.  Briefly,  compartments  are  detected  by  calculating  the  first
component  of  a  PCA of  chromosome-wide  matrices  and  assigning  A compartments  to
genomic bin with positive PCA1 values and high genes density (Fig.  6b).  Conversely, B
compartments  are  assigned  to  genomic  bin  with  negative  PCA1 values  and  low genes
density. TADs were identified using 40 Kb resolution vanilla normalized and decay corrected
matrices  as  input  to  the  TAD  detection  algorithm  implemented  in  TADbit.  TAD  border
localization as well as strength was calculated and used to identify conserved borders and
their strength (Fig. 6c-e). A border was considered conserved between siControl and siSA1
or siSA2 experiments if  it  was localized within +/-  2  two bins in both experiments.  Raw
matrices normalized by coverage (that is,  all  three experiments were scaled to have the
same number of final valid interactions) at 100Kb resolution were also used for studying Hi-C
interactions  as  function  of  genomic  distance.  This  genomic  decay  was  obtained  per
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chromosome to  a  maximum genomic  distance  of  50Mb and then averaged to  obtain  a
genome-wide curve in siSA1 and siSA2 experiments (Fig. 6f). The same 100Kb matrices
were used to determine differential Hi-C interactions between siControl and siSA1 or siSA2
experiments (Fig. 6g). These differential interactions maps were then used to assess the
chromosome average differential interaction as a function of compartment localization and
separating  then in  intra-  and inter-TAD (Fig.  6h).  Finally, the  enrichment  or  depletion of
genes (represented by their TSS), RNA (based on RNA-seq data), and CTCF and cohesin
binding  sites  (SA1-only,  SA2  and  common)  was  analyzed  by  a  log  odds  analysis  of
observing such features in genomic bins belonging to A, B compartments, A/B borders or
TAD borders (Fig. 6i). The log odds distributions were assessed for their distribution being
statistically different than zero as for a Fisher exact test (p-value <0.005).
Code  availability.  TADbit  used  for  Hi-C  analyses  is  freely  available  as  a  github
repository at  https://github.com/3DGenomes/tadbi  t
UCSC  browser  session  with  ChIP-seq  data,  chromatin  states  and  HMEC  super
enhancers tracks is available using the following link: http://genome-euro.ucsc.edu/cgi-
bin/hgTracks?hgS_doOtherUser=submit&hgS_otherUserName=Dinamica
%20cromosomica&hgS_otherUserSessionName=Reviewers%20Session
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In  the  previous  section,  I  have  discussed  that  in  addition  to  its  canonical  function  in
mediating sister  chromatid cohesion,  cohesin is essential  for  genome organization. Such
important  role  is  related with  cohesin  ring  ability  to  entrap  two DNA fragments  “in  cis”,
resulting  in  the  establishment  of  chromatin  loops  and  TADs.  Two  versions  of  cohesin
complex exist in somatic vertebrate cells, cohesin-SA1 and cohesin-SA2, and they are both
present in all cell types. Even though no thorough dissection of the functional specificities of
the two complexes has been conducted, work from our group and from other laboratories
hinted to their non-redundant functions. Supporting the existence of functional specificities
for  both  of  cohesin  variant  complexes,  in  the  last  years  it  became  clear  the  specific
contribution of SA2 mutations in a number of human cancers.
Therefore,  the  main  goal  of  this  work  is  to  explore  the  functional  differences  between
cohesin-SA1 and cohesin-SA2 as well as to investigate the molecular basis underlying such
specific functions. To this end, I have followed a functional genomics approach by combining
the  analysis  of  the  genome-wide  distribution  of  cohesin-SA1  and  cohesin-SA2  across
several  non-tumorigenic  human  cell  lines  with  the  distribution  of  CTCF  and  number  of
histone modifications that define chromatin states in those same cell lines.  The differential
contribution of the two complexes to regulation and genomic organization was investigated
by combining RNA-seq and 3C-derived techniques,  in  particular  4C and Hi-C in  human
mammary cells depleted from cohesin-SA1 or cohesin-SA2 by means of small interfering
RNA (siRNA) technology. 
1. Distinct genome-wide distribution cohesin-SA1 and cohesin-SA2
1.1. Relative abundance of cohesin variants in human cell lines from different origin
It has previously been reported that the relative abundance of cohesin-SA1 and cohesin-SA2
differs among cell types (Losada et al., 2000). In order to avoid biases due to unbalanced
amounts of the two cohesin variants, we decided to select a cell line with comparable levels
of both complexes to carry out our study. With this aim, we measured the levels of cohesin
and the relative abundance of SA1 and SA2 in ten human cell lines representing different
tissues and lineages by quantitative immunoblot (Figure R1). 
We first compared the levels of total cohesin by measuring RAD21 signals and normalizing
them to those of histone H3. Cohesin was most abundant in human mammary epithelial cells
(HMEC),  followed by  cardiac  endothelial  cells  (HCAEC)  (Figure  R1b).  To determine the
amounts of chromatin-bound SA1 and SA2, we performed a chromatin fractionation assay
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for each cell line and assessed SA1 and SA2 levels by comparison with known amounts of
purified C-terminal fragments of the two proteins (Figure R1c). Upon calculating and plotting
the ratio between them, we observed that lung and mammary epithelial cells (NHBE and
HMEC, respectively) were the  cell lines that had the most comparable levels of SA1 and
SA2 on chromatin (Figure R1d). Since HMEC also had more cohesin, we decided they were
the most suitable cells for our study.
Figure R1. Cohesin variant abundance in different cell types
a. Immunoblot  of  total  extracts  from human primary  cells  (NHEK,  Normal  Human Epithelial
Keratinocytes;  PrEC,  Prostate  Epithelial  Cells;  NHBE,  Normal  Human Bronchial  Epithelial
Cells; NHA, Normal Human Astrocytes; HCAEC, Human Coronary Artery Endothelial Cells;
SKMC, Skeletal  Muscle Cells;  HMEC, Human Mammary Epithelial  Cells;  HUVEC, Human
Umbilical Vein Endothelial Cells; NHOst, Normal Human Osteoblasts) and MCF10A cells. 
b. Quantification of the RAD21 signals (normalized to H3) for  the blot shown in a.
c. Known amounts of C-terminal fragments of SA1 and SA2 (around 50 kDa each) were run
alongside the indicated fractions from MCF10A cells to assess relative abundance of cohesin-
SA1 and cohesin-SA2 on chromatin (T, total cell extract; Cyt, cytosolic fraction; N, Soluble
Nuclear Fraction; Chr, Chromatin bound protein). The dotted line indicates that two parts of
the film corresponding to the same exposure but different sizes have been pasted together.
This was repeated with all cell lines used in A (not shown). 
d. Histograms for SA2:SA1 ratio in the indicated cell lines.
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1.2. Genomic distribution of cohesin variants in mammary epithelial cells identifies 
SA2-only positions lacking CTCF
Chromatin  Immunoprecipitation  coupled with deep sequencing (ChIP-seq)  in  HMEC was
performed for the two SA isoforms as well as the common subunit SMC1 in order to warrant
the specificity and reliability of the cohesin binding sites. We used custom made, validated
antibodies and sequenced to high depth (around 100 million reads per antibody) to ensure
whole genome coverage. Reads were aligned to hg19 version of human genome and peaks
were called using MACS2 peak caller, setting FDR to <0.01. The number of peaks called for
each antibody was: 45,985 for SA1, 82,077 for SA2 and 68,673 for SMC1. By overlapping
called peaks using 'BEDtools intersect' utility we defined three different categories of cohesin
positions:  common (42,475),  SA1-only  (3,198)  and SA2-only  (39,061).  Common cohesin
positions  had called  peaks for  both  SA1 and SA2,  whereas for  SA1-only  and SA2-only
positions peaks were called for SA1 and not SA2 or SA2 and not SA1, respectively (Figure
R2). These results showed that more than 90% of peaks called for SA1 are shared with SA2,
while in contrast, in almost 50% of SA2 positions there is very little or no SA1. 
Figure R2. Three different categories of cohesin binding sites in HMEC 
Venn diagram showing the overlap among the positions called for each cohesin subunit. On the
right, percentage of positions in each of the three categories defined in the main text.
In order to better characterize these categories of cohesin positions and to check that SMC1
was present -even if the peak was not called- in all the SA1 and SA2 positions, we next
generated heatmaps in  which the reads from each experiment  were plotted around the
summits  of  the  called  peaks in  the  three categories  as well  as the corresponding read
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density plots (Figure R3). Common cohesin positions were featured by high occupancy of
cohesin  and  similar  read  density  for  SA1  and  SA2.  For  both  SA1-only  and  SA2-only
positions, read density of SA1 and SA2 was lower than in the case of common positions.
Importantly,  while  there  was  little  SA1  in  SA2-only  positions,  SA2  was  still  significantly
enriched in SA1-only positions. 
Next we asked about the presence CTCF in these positions for which we used data publicly
available. Read density heatmaps and plots showed that CTCF was present in common
cohesin positions and to a lesser extent, also in SA1-only positions. In contrast, SA2-only
positions had undetectable levels of CTCF (Figure R3).  Taken together, our data suggest
that cohesin-SA1 function is largely related to that of CTCF, while cohesin-SA2 could have a
unique, CTCF-independent function in approximately half of its positions.
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Figure R3. Three different categories of cohesin binding sites in HMECs 
Analysis of ChIP-seq read distribution for SA1, SA2, SMC1 and CTCF around common, cohesin
SA1-only and cohesin SA2-only positions within a 5-kb window in HMECs (top) and read density
plots for SA1 (red) and SA2 (blue) distribution in common, SA1-only and SA2-only positions as
well as for CTCF (separate plot on the right).
An additional  advantage  of  the  HMEC cell  line  is  the  availability  of  a  broad  number  of
genomic  data,  including  histone  marks  such  as  H3K27Ac,  H3K4Me3,  H3K4Me1,
51
Results
H3K27Me3,  which  permit  the  proper  definition  of  chromatin  states  (Ernst  et  al.,  2011).
Overlap of cohesin positions with the chromatin states defined in HMEC revealed differential
distribution of the two cohesin variants in the different genomic features. Around  40% of
common positions were present at insulators, a state defined by the sole presence of CTCF,
while 35% occurred within strong or weak enhancers (Figure R4). Some SA1-only positions
were also found in insulators (23%) and enhancers (10%) but most were present in a chromatin
state  designated as  “heterochromatin/low signal”,  a poorly  defined state  likely  related with
silent or inaccessible genomic regions. Importantly, most (80%) of SA2-only positions were
found  in  enhancers,  particularly  strong  ones,  and  there  was  also  a  fraction  in  active
promoters that  was larger  than the fraction  of  common sites  in  that  state.  This  specific
enrichment of SA2-only positions in active regions suggests a prominent role of SA2 in the
regulation of gene expression.
Figure R4. Most SA2-only cohesin positions are located in enhancers 
Pie charts showing the distribution of cohesin positions in chromatin states defined in HMECs
 
Current  models  hold  that  cohesin  binds  DNA topologically  without  recognizing particular
DNA motifs, but the role of CTCF as a boundary element stopping loop extruding cohesin
leads  to  their  colocalization  at  CTCF binding  sites.  The  absence  of  CTCF at  SA2-only
positions  prompted  us  to  investigate  the  possible  molecular  determinants  of  CTCF-
independent cohesin activities at these positions. We performed motif discovery analysis in
all three categories of cohesin sites using “MEME-ChIP” utility within MEME suit (Bailey et
al.,  2009;  http://meme-suite.org/). MEME is  used for  discovery of  novel,  ungapped DNA
binding motifs within sequences of interest. MEME-ChIP (Machanick and Bailey, 2011) is a
powerful tool for discovery and comprehensive analysis of DNA binding motifs performed on
large sets of sequences coming from ChIP-seq experiments. In order to investigate all the
transcription factors that could be located around cohesin positions we decided to extract the
complete  sequences recovered by  ChIP-seq peaks (average size  400-500bp)  and used
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them as input for MEME. One thousand randomly chosen sequences were selected from
each category of positions. Both common and SA1-only positions were significantly enriched
in CTCF binding motif,  an expected result given the presence of CTCF in most of these
positions (Figure R3). In contrast, SA2-only positions were enriched in binding motifs for a
number  of  different  transcription  factors  including  several  members  of  the  AP-1  family
(Figure R5). In view of these data, we can conclude that while the function of cohesin-SA1 is
exclusively  and  tightly  related  to  CTCF,  cohesin-SA2  could  have  specific  and  CTCF-
independent functions, likely related to the regulation of transcription.
Figure R5.  Transcription factor  binding motives other  than CTCF at  SA2-only cohesin
positions 
Motif-based  analysis  of  the  indicated  positions  in  HMEC  cells.  E-values  of  the  significantly
enriched  motifs  and  percentage  of  regions  containing  each  motif  for  a  given  condition  are
indicated. “TF” column contains the transcription factors with statistically significant binding (blue
scale, on the right) to the identified motifs.
1.3. Identification of SA2-only positions in cardiac endothelial cells
To assess the general validity of our previous conclusions, we carried out analyses similar to
those  in  HMECs  in  a  cell  line  of  different  embryonic  origin.  We chose  human  cardiac
endothelial  cells  (HCAEC) since,  as  HMECs,  they displayed high levels  of  cohesin  and
similar SA1:SA2 ratio (Figure R1). With a sequencing depth of about 70 million reads per
antibody (SMC1, SA1, SA2), the MACS2 algorithm and FDR<0.05, we obtained 40,796 and
39,072 called peaks for SA1 and SA2, respectively. This time we identified 30,034 common,
9,642 SA1-only and 7,942 SA2-only positions (Figure R6a). The read density profile plots
demonstrated higher read density for SA1 than SA2 in common positions suggesting that the
SA2 ChIP had been less efficient in these cells (Figure R6). We suspect that this has two
consequences:  first,  that  many  SA2-only  positions  with  low  cohesin  occupancy  go
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undetected and second,  that  a fraction of  the positions defined as SA1-only  are in  fact
common positions. 
As in the case of HMEC, the levels of SA1 in SA1-only and of SA2 in SA2-only positions
were lower than in common positions. Importantly, when we plotted the reads from CTCF
distribution  for  a  related  cell  line  of  endothelial  origin  (HUVEC,  human  umbilical  vein
endothelial  cell),  we confirmed that  SA2-only  positions lacked CTCF. Similar  also to our
findings  in  HMECs,  SA2 could  still  be  detected in  SA1-only  called  positions,  and these
positions also showed high overlap with CTCF. Moreover, using the chromatin states defined
for HUVEC (Ernst  et  al.,  2011),  we found enrichment of  common positions in  insulators
(48%) and enhancer elements (36%) while SA2-only sites were mostly present at strong
enhancers (65%) (Figure R6b). Thus, our analysis demonstrated that the presence of CTCF-
independent, SA2-only cohesin positions located at enhancers is a common feature shared
by different cell lines.
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Figure R6. Identification of SA2-only positions at enhancers in cardiac endothelial cells
a. Analysis  of  ChIP-seq read distribution  for  SA1,  SA2,  SMC1 and CTCF around common,
cohesin SA1-only and cohesin SA2-only positions within a 5-kb window in HCAECs (top) and
read density plots for SA1 (red) and SA2 (blue) distribution in common, SA1-only and SA2-
only positions as well as for CTCF (separate plot on the right).
b. Pie charts showing the distribution of cohesin positions in chromatin states defined in HUVEC.
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A role for cohesin non-CTCF positions in the control of cell-type specific gene expression
was suggested several years ago (Schmidt et al., 2010). In line with this, our analysis of
cohesin distribution in two different cell lines suggests that SA2-only sites could have CTCF-
independent cohesin roles. In order to test whether SA2-only positions are indeed cell-type
specific, we overlapped cohesin positions defined in HMEC and HCAEC (Figure R7). While
common positions were largely conserved between the two cell lines, this was not the case
for SA2-only sites, confirming the cell-type specificity of this category of cohesin positions.
Figure R7.  Transcription factor  binding motives other  than CTCF at  SA2-only cohesin
positions 
Venn diagrams showing overlap of  cohesin binding sites in  the different  categories between
HMECs and HCAECs
In summary, our data demonstrate that cohesin-SA2 is the main variant at cohesin positions
devoid of CTCF. These SA2-only positions are enriched at genomic regulatory elements,
specially enhancers,  containing DNA binding motifs for  different  transcription factors.  We
postulate that cohesin-SA2 is responsible for CTCF-independent roles of cohesin exerted
from positions co-occupied by transcription factors other than CTCF. Moreover, we observed
that  SA2-only  positions  are  variable  between  different  cell  lines,  suggesting  that  these
positions  might  be  responsible  for  tissue-specific  gene  regulation.  On  the  other  hand,
majority  of  cohesin-SA1  binding  events  do  contain  some  SA2  and  CTCF,  and  their
distribution in chromatin states resembles that of common positions. Intriguingly, SA1-only
positions are also quite different between HMEC and HCAEC, opening the possibility that
such positions might play a functional role different to common ones.
1.4. Genomic distribution of cohesin variants in MCF10A cells
In order to further understand the functional specificities of the two variant complexes, we
turned to a cell line that would be easier to grow and to transfect than the primary cell lines.
We chose MCF10A, a transformed, non-tumorigenic cell line of human mammary epithelia
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and  first  examined  the  genome-wide  distribution  of  cohesin  variants.  ChIP-seq  assays
analysed as above yielded 50,299, 22,510 and 37,308 positions for SMC1, SA1 and SA2,
respectively. By overlapping the called peaks we defined 20,154 common, 15,224 SA2-only
and a very small number (1,489) of SA1-only positions. Read density of SA1 and SA2 in
common positions was similar and the enrichment of CTCF around those sites was high
(Figure  R8).  Most  SA1-only  positions  also  contained  some  CTCF  and  SA2,  and  its
distribution in chromatin states was similar to that of common positions with a prevalence in
insulators (Figure R9).
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Figure R8. Three different categories of cohesin binding sites in HMECs 
Analysis of ChIP-seq read distribution for SA1, SA2, SMC1 and CTCF around common, cohesin
SA1-only and cohesin SA2-only positions within a 5-kb window in MCF10A cells (top) and read
density  plots  for  SA1  (red)  and SA2 (blue)  distribution  in  common,  SA1-only  and  SA2-only
positions  as  well  as  for  CTCF  (separate  plot  on  the  right).  SA2-only  position  have  been
subdivided in two clusters. Cluster 1 groups positions that are most likely common positions in
which SA1 ChIP efficiency was lower.
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Among SA2-only positions, read distribution heatmaps distinguished two clusters. Cohesin
positions in both clusters were enriched in SA2, but those in cluster 1 contained also some
SA1 and CTCF and its distribution among chromatin states was not very different to that of
common  positions  (Figure  R9).  The  larger  cluster  2,  in  contrast,  comprised  SA2-only
positions  without  CTCF  and  were  enriched  in  enhancers  and  depleted  in  insulators
compared with common and SA1-only positions. Taken together these analysis support that
MCF10A cells constitute an appropriate cell model for our next experiments.
Figure R9. Most SA2-only cohesin positions are located in enhancers 
Distribution of cohesin positions identified in MCF10A in chromatin states defined in HMECs. 
1.5. Cohesin-SA2 interacts with transcriptional regulators
Aimed  to  identify  specific  partners  of  cohesin-SA2  responsible  for  CTCF-independent
cohesin  functions,  we  performed  mass-spectrometry  analysis  of  immunoprecipitates
obtained from MCF10A cell extracts with either SA1 or SA2 antibodies, and IgG as control.
Cohesin subunits and its regulators could be identified in both cases (Figure R10a), but a
number  of  transcriptional  regulators were detected only  in  the  SA2 pull  down,  including
ZMYM2 and YAP1 (Figure R10b). ZMYM2 function is related with transcriptional repression
through  its  association  with  the  CoREST  complex  while  YAP1  is  a  transcriptional  co-
activator. To corroborate these results, we examined the genomic distribution of ZMYM2 in
MCF10A by ChIP-seq and obtained 1,243 peaks. The heatmap and read density profiles of
SA1, SA2 and CTCF centred at ZMYM2 peak summits demonstrated that there is a clear
preference  for  SA2  at  those  positions,  while  CTCF and  SA1  are  absent.  Likewise,  re-
analysis of a ChIP-seq dataset for activated YAP1 from another study (Jang et al., 2017)
according to our parameters yielded 9,393 peaks that, as in the case of ZMYM2, showed
specific enrichment of SA2-only positions (Figure R10c). 
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The data from the proteomic analysis together with the specific enrichment of SA2 positions
around the transcriptional regulators ZMYM2 and YAP1 strongly suggest that cohesin-SA2 is
responsible  for  CTCF-independent  cohesin  functions  through  its  association  with
transcription factors. 
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Figure R10. Cohesin-SA2 interacts with transcriptional regulators 
a. Table showing th mass spectrometry (MS) counts obtained for cohesin and its regulators in
the immunoprecipitates obtained from MCF10A cell extracts with antibodies against SA1 and
SA2 but not IgG (control). 
b. Identification of  significant  differential  interactions for  SA1 and SA2. Dark grey dots  show
proteins  significantly  enriched  compared  with  the  mock  immunoprecipitation  using  IgG.
Proteins whose function is related with transcriptional regulation are indicated in blue.
c. Distribution of SMC1, SA1, SA2 and CTCF around ZMYM2 and activated YAP (YAP-5SA)
positions (± 2.5 kb) defined by ChIP-seq in MCF10A cells.
2. Different dynamics of cohesin-SA1 and cohesin-SA2 association with 
chromatin
We wished to understand the molecular determinants responsible for the different genomic
distribution and relationship with CTCF and other chromatin binding proteins exhibited by
both cohesin variants. The experiments reported in this section aimed to explore differences
in  their  dynamic  association  with  chromatin  that  could  account  for  their  functional
specificities.
2.1. Cohesin complex is more dynamic in SA2-only than in common positions
Close visual inspection of SMC1 read density plots, revealed that while the distribution of
SMC1 reads around common and SA1-only positions produces sharp and narrow profiles in
the three cell  lines under study, such distribution around SA2-only  positions gives much
broader profiles (Figure R11). Consistently, SA1 and SA2 profiles around common positions
are  also  sharp  and  narrow. This  observation  suggests  that  cohesin  bound  at  SA2-only
positions is more dynamic than cohesin bound at common or SA1-only sites.
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Figure R11. Different behavior of cohesin at common and SA2-only positions 
Average  read  density  plots  for  SMC1  ChIP-seq  reads  in  the  SA1-only, SA2-only  (top)  and
common (bottom) cohesin positions identified in the three human cell lines indicated. 
A plausible explanation to this behaviour is that cohesin at common positions is less prone to
be removed from chromatin by the activity of WAPL when compared to cohesin at SA2-only
positions. To test this hypothesis,  we measured the levels of  SA2 and WAPL at  several
common and SA2-only positions from by ChIP-qPCR (Figure R12a). SA2/WAPL ratio was
much higher at common positions than SA2-only positions. This suggests that cohesin at
common positions  is  less  likely  to  associate  with  WAPL and be removed by its  activity
compared to SA2-only positions.
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Figure R12. Cohesin is less likely to associate with WAPL at common positions 
a. SA2 and WAPL binding to three common (c2,c3,c4) and four SA2-only positions (o1, o2, o4,
o5) from the S100 gene cluster described in next section were assayed by ChIP-qPCR. Bars
represent the mean of at least three independent experiments performed in triplicates; error
bar=SD 
b. Read density plots showing cohesin SMC1 distribution in wild type (wt) and WAPL knockout
(KO) human HAP1 cells. Cohesin positions were classified into common and SA2-only based
on their co-occurrence with CTCF in WAPL KO cells.
If  this idea were correct,  one would expect that elimination of WAPL would increase the
amount of chromatin bound cohesin at SA2-only positions more than at common positions. A
recent study in human leukemic HAP1 cells aimed to analyse the consequences of WAPL
removal on chromatin loop dynamics provided data on SMC1 and CTCF distribution in wild
type and WAPL KO cells (Haarhuis et al., 2017). We decided to test our prediction with these
data. First, to identify common and SA2-only positions, we re-analysed ChIP-seq data and
assumed that  those cohesin  positions  that  lack  CTCF were actually  SA2-only  positions,
while those positions in which cohesin colocalized with CTCF were common positions. When
we checked the read density of  SMC1 in both conditions we found that  the increase of
SMC1 at SA2-only positions was almost double the increase at common positions (Figure
R12b). These findings support the idea that WAPL removes more efficiently cohesin bound
at SA2-only positions. Interestingly, a mass-spectrometry analysis performed to identify SA1
and SA2 specific interactors revealed stronger preference of WAPL for cohesin complexes
containing SA2 (Figure R10a). 
2.2. Cohesin-SA2 is less stably bound to chromatin than cohesin-SA1
After  observing  that  binding  of  cohesin  is  more  dynamic  in  SA2-only  positions  than  in
common positions we decided to further explore the stability of chromatin association of the
two SA variants using a salt extraction experiment. To this end, the chromatin fraction of
MCF10A cells was treated with two different concentrations of salt (0.25M or 0.5M NaCl) for
either 10 or 20 min and the amount of each variant remaining on chromatin was assessed by
immunoblotting. We found that SA2 was more sensitive to the salt than SA1, as seen at all
time points in the lower salt treatment. At higher salt the enhanced sensitivity of SA2 could
be seen at the shorter time point (Figure R13). We conclude that the association of cohesin-
SA2 with chromatin is less tight or, in other words, more dynamic, than the association of
cohesin-SA1. It is possible that the higher resistance of cohesin-SA1 to salt stems from its
preferential association with CTCF.
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Figure R13. Cohesin-SA2 binds less tightly to chromatin than cohesin-SA1 
Remaining cohesin on chromatin after treatment of chromatin fractions with 0.25M and 0.5M
NaCl for the indicated times was assayed by quantitative immunoblotting. Quantification is shown
on the right.
2.3. More than one cohesin complex can coexist in the same position in a single cell
One important question in the field is whether more than one cohesin complex can occupy
the same position in  a given cell.  The fact  that  cohesin complexes carrying one of  two
distinct subunits, SA1 or SA2, can be found by ChIP at the common positions, gave us the
opportunity  to  address  this  question  using  Re-ChIP. This  assay  involves  two  sequential
rounds  of  immunoprecipitation,  using  antibodies  specific  for  the  two  proteins  whose
colocalization is to be tested. We evaluated cohesin enrichment at five common positions
and two “negative” regions selected based on our ChIP-seq data in MCF10A cells. After the
first  immunoprecipitation,  we  observed  specific  enrichment  of  both  cohesin  variants  at
common positions, as expected, but not at negative regions, while no binding was detected
with  the IgG (Figure  R14,  upper  panel).  After  elution  of  chromatin  from antibodies  and
thorough washes, the second round of immunoprecipitations was performed with SA2 in
SA1  immunoprecipitated  chromatin  (second  panel  from  top)  and  with  SA1  in  SA2-
immunoprecipitated  chromatin  (third  panel  from  the  top).  As  control,  both  were  also
immunprecipitated with SMC1 and IgG as positive and negative controls, respectively. The
latter Re-ChIP sets the background level, since it reflects the antibody carry over from the
first ChIP. One further control was to immunoprecipitate the chromatin eluted from IgG beads
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in  the  first  immunoprecipitation  with  SA1  or  SA2  antibodies,  which  gave  no  significant
enrichment in any of the studied regions (Figure R14, lower panel).
Figure R14. Two cohesin complex can coexist at the same position 
Re-ChIP assay. Chromatin eluted from the first ChIP with SA1 or SA2 was incubated with SA2
and SA1 antibodies, respectively, as well as SMC1 and IgG as positive and negative controls.
Lower panel, Re-ChIP of chromatin eluted from IgG beads with SA1 and SA2. Positions c3-c8
are "common" cohesin binding sites; n1 and n2 are negative regions.
Upon removal of the first antibody (SA1 or SA2) and incubation with the second antibody
(SA2 or SA1 respectively), we could detect cohesin enrichment over the IgG background in
all the cohesin binding sites tested (second and third panels from top in Figure R14). The
incubation  of  SA1  or  SA2  immunoprecipitates  with  anti  SMC1  as  the  second  antibody
confirmed cohesin enrichment. 
In an attempt to further explore the genomic regions where both cohesin isoforms coexist
simultaneously, we generated ChIP-seq libraries from some of the samples of the Re-ChIP
experiment, SA2&SA1 and SA2&IgG. Preparing these libraries was specially challenging,
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due to the limited amount of available material. In spite of the technical limitations, upon
using  SA2&IgG  signal  as  the  "input"  in  the  peak-calling  step,  we  obtained  201  called
positions in  the SA2&SA1 Re-ChIP condition.  Heat  map density  plots  of  SA1,  SA2 and
CTCF centered on those Re-ChIP positions and its distribution in chromatin states showed
that all of them correspond with common sites (Figure R15). 
Figure R15. Genome-wide assessment of sites occupied by two cohesin complexes 
Heatmaps showing the distribution of the indicated proteins around the 201 positions obtained
after  ChIP-seq  analyses  of  the  chromatin  obtained  by  Re-ChIP of  SA2  and  SA1  (top)  and
distribution of these positions in chromatin states.
Altogether,  these  data  suggest  that  at  least  two  different  cohesin  complexes  can
simultaneously be present in the same genomic location within the same cell. 
2.4. Cohesin-SA1 cannot occupy SA2-only sites in SA2-depleted cells 
To understand  if  cohesin-SA1  and  cohesin-SA2  can  replace  each  other  and  therefore
assume their respective specific functions in situations where their relative levels change, we
studied their genomic distribution upon SA1 or SA2 depletion using calibrated ChIP-seq.
Calibrated ChIP-seq involves mixing the sample under study with a little amount (20% in our
experiments)  of  chromatin  from  a  different  species,  the  "calibration”  sample,  whose
sequences  can  be  easily  distinguished  during  the  aligning  process,  and  in  which
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experimental steps of fixation, sonication and Immunoprecipitation work in a similar fashion.
An  important  requirement  is  that  the  protein  expressed  by  both  the  calibration  and  the
experimental  species  is  recognized  by  the  antibody  used  for  immunoprecipitation.  The
“calibration” genome is used as an internal control for the experiment, which helps to more
accurately  compare samples  immunoprecipitated with  the same antibody under  different
conditions (Hu et  al.,  2015).  MCF10A cells were transfected with  small  interfering RNAs
(siRNAs) specific for SA1 or SA2 or mock transfected as control and downregulation of each
protein was assessed by immunoblotting (Figure R16). 
Figure R16. Downregulation of SA1 and SA2 by in MCF10A cells by siRNA
Cell  were  mock  transfected  (siC)  or transfected  with  siRNA against  SA1  (siSA1)  and  SA2
(siSA2).  After  72h they  were  collected  and the  depletion  of  SA1 and SA2 was checked by
immunoblotting. Transfections were carried out in triplicates with similar efficiency.
ChIP was performed in  duplicate  with SA1 and SA2 antibodies  in  mock,  SA1 and SA2
depleted cells. Around 20% and 80% of the total number of reads obtained in each condition
aligned to the mouse and human genomes, consistent with the ratio in which mouse and
human chromatin were mixed (see Tablexx in Appendix). We first generated heatmaps with
the reads that  aligned to the mouse genome to  show the degree of  technical  variation
among replicates and conditions (Figure MM1). 
Next  we  generated  heatmaps  and  read  density  profiles  for  SA1  and  SA2  in  the  three
conditions and centered them at summits of previously defined common, SA1-only and SA2-
only positions in MCF10A cells (Figure R18). We observed that, in SA1 depleted cells, there
was little cohesin-SA1 left at any position while the presence of cohesin-SA2 increased both
at  common and SA2-only  sites compared to mock transfected cells.  Importantly, in  SA2
depleted  cells,  cohesin-SA1  could  not  occupy  cohesin-SA2  only  sites  and  instead
accumulated further at common positions. We conclude that both cohesin-SA1 and cohesin-
SA2 can reach common binding sites independently of each other. Thus, in the absence of
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one variant, the other could at least partially compensate for its loss at these CTCF bound
sites.  In  contrast,  cohesin-SA1 cannot  occupy cohesin-SA2 only  positions  when SA2 is
missing.  This  suggests  that  cohesin  functions  dependent  on  those  positions  could  be
severely impaired in SA2-depleted cells.
Figure R18. Cohesin-SA1 cannot replace cohesin-SA2 at SA2-only positions
Heatmaps (left) and read density plots (right) showing SA1 and SA2 distribution around cohesin
positions defined in Figure R8 in control cells, SA1 depleted cells and SA2 depleted cells. Two
independent replicates were performed per condition. Read density plots were built merging the
reads from the two replicates.
3.  Differential  contribution  of  cohesin  variants  to  the  control  of  gene
expression
3.1. Depletion of SA1 or SA2 has different impact on the transcriptome of MCF10A
cells 
We have demonstrated that the existence of different categories of cohesin positions is a
general feature of all cell lines. Unpublished results from our group confirm their presence in
mouse embryonic stem cells and fibroblasts. While common cohesin-SA1 and cohesin-SA2
positions  are  conserved in  different  cell  types and largely  overlap with  CTCF, SA2-only
positions  are  cell-type  specific,  CTCF-free,  and  are  located  in  enhancers  and  active
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promoters  together  with  transcription  factors.  Based  on  these  results,  it  is  tempting  to
propose that cohesin isoforms might have different roles in gene expression, being SA2 the
most relevant cohesin in the control of cell-type specific transcription. To test this hypothesis,
we decided to analyse the changes in the transcriptome of MCF10A cells upon depletion of
SA1, SA2 or CTCF using RNA-seq.
Figure R19. Most SA2-only cohesin positions are located in enhancers 
a. Levels of cohesin and CTCF after siRNA transfection in MCF10A cells. Cells were also mock
transfected (siC) and transfected with siRNA against SMC1 (siSMC1) for comparison. The
amount of cohesin (SMC1) remaining in each condition is shown below. Tubulin is shown as
loading control.
b. Venn diagram showing the overlap between genes deregulated in  the indicated condition
compared to mock transfected cells (FDR<0.05, log2fold change <-0.5 or >0.5 and FPKM >3
in at least one condition). Experiments for siSA1 and siSA2 were performed in triplicate where
for CTCF to replicates were analysed.
We transfected MCF10A cells with small interfering RNAs (siRNAs) specific for SA1, SA2
and CTCF. Cells were collected 72 hours after transfection and the remaining protein levels
were assessed by immunoblot (Figure R19a). The efficiency of SA1 and SA2 depletion was
comparable and,  importantly, decreased expression of  each of  the SA variants  led to a
similar  reduction  of  total  cohesin  amount,  as  indicated  by  SMC1  levels.  As  previously
described, depletion of CTCF, had no impact on cohesin. RNA was extracted from the cells
and analysed and libraries were prepared for sequencing.
In  order  to  ensure  significant  and  meaningful  transcriptional  changes,  we  applied  the
following criteria to our RNA-seq analysis:  FPKM>3 in at least one of the two compared
conditions and FDR<0.05 and log2 fold change <-0.5 or >0.5 for differential expression. As a
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result, we obtained 157 and 716 differentially expressed genes (DEGs) upon depletion of
SA1 and SA2 respectively. This number raised to 1,191 in the case of CTCF depleted cells
(Figure R19b). Interestingly, as many as 493 genes SA2-dependent genes were not affected
by CTCF depletion, confirming a prominent CTCF-independent role for SA2 in the regulation
of transcription. On the other hand, most DEGs found in SA1 depleted cells (101 out of 157)
were also found to be deregulated upon depletion of SA2 or CTCF suggesting that, indeed,
the transcriptional role of cohesin-SA1 is tightly linked to the activity of these two proteins.
3.2. Cohesin-SA2 contributes to maintain cell-type identity
We  have  just  shown  that  depletion  of  SA2  has  stronger  impact  on  transcription  than
depletion of  SA1 and that this effect  is largely CTCF independent.  Aimed to identify the
consequences of these transcriptional changes and the biological processes affected, we
performed Gene Set Enrichment Analysis (GSEA) with the transcriptomic data from SA1,
SA2 and CTCF depleted cells. Significant upregulation of pathways related to the nervous
system and the hematopoietic cell  lineage was observed specifically upon SA2 depletion
(Figure R20a). This result could reflect a certain degree of loss of cell identity under this
condition 
Individual inspection of DEGs in SA2 depleted cells further revealed abnormal expression of
genes known to be important tissue-specific transcription factors. In particular, one of the
genes that appeared on top of the list of genes upregulated in siSA2 cells was BDNF (Brain
Derived Neurotrophic  Factor),  an  important  neuronal  transcription  factor. Of  note,  BDNF
expression is known to be repressed in non-neuronal tissues by the activity of CoREST
complex (Ballas et al., 2005). In addition, Irx3 and Tfap2c, two core transcription factors in
mammary  gland  cells  (D’Alessio  et  al.,  2015)  were  found  down-regulated  upon  SA2
depletion.  These  findings  suggest  that  cohesin-SA2  is  contributing  to  maintain  cell-type
identity by regulating the expression of tissue-specific core regulators.
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Figure R20. Cohesin-SA2 contributes to maintain cell identity  
a. Enrichment  plots  for  genes within  KEGG pathways specific  for  the  hematopoietic  system
(“Hematopoietic  cell  lineage”)  and  the  nervous  system  (“Neuroactive  Ligand-Receptor
interaction”)  after  downregulation  of  SA1,  SA2  or  CTCF.  Both  these  pathways  appear
significantly upregulated in the siSA2 condition (NES>0, in red; FWER q-value<0.01). In the
other two conditions the gene expression changes are either not significant (FWER q-value in
grey) or in the opposite direction (NES<0, in blue). Y axis, enrichment score (ES).
b. Gene expression levels (in FPKMs) of cell-type specific transcription factors  in control (siC),
siSA1, siSA2 and siCTCF conditions from the RNA-seq analysis. Student's T test was used to
assess statistical significance.
To further confirm this hypothesis, we examined the relative enrichment of the two cohesin
SA isoforms in the super-enhancers (SEs), which play an essential role in the control of
mammalian cell identity (Hnisz et al., 2013). These regulatory elements consist of clusters of
enhancers  that  are  densely  occupied  by  cell-type  specific  master  regulators  and  the
Mediator  complex.  SEs differ  from typical  enhancers in  size,  transcription  factor  binding
density and content, ability to activate transcription and sensitivity to perturbation. They were
initially discovered in ESCs as regulatory elements present at most genes that control the
pluripotent state, densely bound by ESC master transcription factors, but their existence and
activity has also been confirmed in differentiated cells (Whyte et al., 2013). Using the list of
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SEs defined for HMECs, we first performed a simple overlap between the three categories of
cohesin  positions  defined in  this  cell  line  and  the genomic  regions  containing  SEs.  We
observed that these regions are specially enriched in SA2-only positions (Figure R21a), and
that this enrichment is cell type specific. 
Figure R21. Cohesin-SA2 is enriched at super-enhancers  
a. Cohesin enrichment in super-enhancers (SE) defined in HMECs 
b. Snapshot of the browser showing distribution of cohesin around an HMEC SE in HEMCs and
HCAECs.
c. Average read density plot showing SA1 and SA2 enrichment in HMEC and HCAECs along all
HMEC SE.
d. Box-plot that compares changes in expression between random genes and genes associated
with HMEC-specific SE. Statistical significance was calculated with a Wilcoxon signed-rank
test. Data from Whyte et al., 2013.
In Figure R21b a HMEC SE is shown that is flanked by common cohesin positions with
bound CTCF and contains additional cohesin-SA2 only peaks lacking CTCF along its more
than 50kb long region. Importantly, the SA2-only positions are present in HMECs, when the
SE is active, but not in HCAECs. Average read-density profiles for SA1 and SA2 ChIP-seq
reads  from  the  two  cell  lines  along  all  HMEC SEs  confirmed  that  cohesin  enrichment,
specially cohesin-SA2, was much lower in HCAEC than in HMEC (Figure R21c). Moreover,
72
Results
increased gene expression levels of  the genes potentially regulated by SEs in HMEC is
found in HMECs compared to the endothelial HUVEC cells while this is not the case in a
control  group  of  randomly  selected  genes  (Figure  R21d).  Taken  together,  these  results
support a role for cohesin-SA2 in cell-type specific transcription.
3.3. Further insights in the role of cohesin-SA2 in gene expression: The S100 cluster
By  close  inspection  of  our  RNA-seq  data  we  noticed  that  a  number  genes  encoding
members of the S100 protein family were significantly downregulated specifically in SA2-
depleted  MCF10A  cells.  S100  proteins  regulate  a  plethora  of  intra-  and  extra-cellular
processes and altered expression of many of them is associated to cancer progression and
poor prognosis (Chen et al., 2014). Interestingly, 22 genes of this family are distributed within
a 300-kb cluster located in chromosome 1q21.  When we examined cohesin distribution in
MCF10A cells in the region containing S100 cluster we observed a number of prominent
common  positions  that  co-localized  with  CTCF  as  well  as  several  SA2-only  positions
featured by lower read density and lack of CTCF overlap. Interestingly, most of these SA2-
only positions were located precisely at the promoters of deregulated S100 genes (orange
dots in Figure R22a). 
We selected four common (c1 to c4) and three SA2-only (o1 to o3) positions and validated
our  ChIP-seq  results  by  quantitative  ChIP-qPCR  (Figure  R22b).  We  also  confirmed  by
quantitative  RT-qPCR   the  specific  downregulation  of  S100  genes  after  SA2  depletion
detected by RNA-seq (Figure R22c). Importantly, depletion of SA1 did not have any impact
on the expression of these genes.
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Figure R22. Cohesin-SA2 is enriched at super-enhancers  
a. UCSC browser image of the S100A gene cluster showing genes (orange dots indicate those
deregulated in siSA2 cells), CTCF peaks and distribution of SMC1, SA1 and SA2 in MCF10A
cells.  Some  common  (c)  and  SA2-only  (o)  positions  are  shadowed  in  red  and  blue,
respectively.
b. ChIP-qPCR validation of SA1, SA2 and CTCF binding to the indicated (c) and (o) positions. 
c. Gene  expression  levels  of  the  indicated  S100  genes  assessed  by  RT-qPCR  (n=3
experiments). Student's T test was used to assess statistical significance.
We next asked if the genomic distribution of cohesin-SA1 and cohesin-SA2 along the S100
cluster would contribute to the architecture of the locus. To answer this question, we first
looked at the spatial organization of the S100A locus using publicly available Hi-C data from
epithelial (HMEC) and endothelial (HUVEC) cells  (Rao et al., 2014)  and observed striking
differences between both cell lines (Figure R23a). 
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Figure  R23.  Cohesin  distribution  correlates  with  genome  organization  and  gene
expression 
a. HiC contact matrices for S100A locus at 5kb resolution in mammary (HMEC) and endothelial
(HUVEC) cells is shown. The intensity of each pixel represents the normalized number of
contacts between a pair of loci. Positions for cohesin subunits and CTCF are indicated below.
b. Expression  levels  of  the  genes  of  the  S100A locus  deregulated  in  siSA2  MCF10A cells
(orange dots in a) in HMEC, HUVEC and HCAEC.
In HMECs we observe frequent and strong contacts within each of the two isolated domains
that encompass this locus (highlighted by dotted lines). In contrast, these interactions are
much  reduced  in  endothelial  cells,  coinciding  with  the  absence  of  SA2-only  positions
specifically in this last cell type. Thus, there seems to be a correlation between the strength
of local interactions within a contact domain and the presence of cohesin SA2-only positions.
Importantly, the expression levels of the S100A genes located within the strongly interacting
domains, are also much higher in mammary than in endothelial cells (Figure R23b). 
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Cohesin and CTCF have been shown to demarcate contact domains. Since cohesin-CTCF
sites contain both cohesin-SA1 and cohesin-SA2, we hypothesized that elimination of SA2
might have no major impact on this demarcation function. To test this hypothesis, we devised
a 4C experiment. As explained in the Introduction, 4C is a 3C-derived technique that allows
the identification of all genomic regions that interact with a defined position or “viewpoint”.
We chose as viewpoint  one of two strong common positions the two subdomains of the
locus (arrow in Figure R23a) and examined its interaction profiles in three conditions: mock
depleted cells as control and cells depleted from SA2 or CTCF. In the control cells, all the
interactions of the locus happen within the subdomain on the right (red curves in Figure
R24).  When  CTCF is  depleted,  reduced  insulation  allows  for  new interactions  with  the
regions to the right of the viewpoint to arise (blue curves in Figure R24). In contrast, and in
line with our hypothesis, SA2 depletion does not have a visible impact in insulation. 
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Figure R24. SA2 depletion does not reduce insulation  
A 4C experiment in S100A locus was performed in MCF10A in mock depleted cells (siC) wand
cells with reduced SA2 (sSA2) or CTCF (siCTCF) levels. A vertical red line and an arrowhead
indicate the viewpoint position. Binding sites of cohesin-SA1, cohesin-SA2 and CTCF identified
by ChIP-seq are also shown. Red curves highlight interactions present in the control cells. Blue
curves indicate new interactions detected after CTCF depletion. The Hi-C contact matrix from
S100A locus at 5kb resolution in HMEC cells from Figure R24 is shown for reference.
Altogether, our data suggest that at least in the context of S100A cluster, SA2 does not play
a major role in maintaining the overall locus structure. However, there is a strong correlation
between the presence of  SA2-only  positions,  the  existence of  local  interactions and the
levels of expression of nearby genes.
4. Hi-C analyses show that cohesin-SA1 and cohesin-SA2 make different 
contributions to genome architecture
Our previous results demonstrate differences in SA1 and SA2 cohesin variants regarding
their  genome-wide  genomic  distribution,  their  relationship  with  CTCF  and  a  number  of
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transcription factors, their functional enrichment in chromatin states and their dynamics on
chromatin. These differences probably account for their distinct impact on gene expression,
which is very likely related with the existence of specific roles of both cohesin variants in the
3D organization of the genome. 
To address the specific contributions of cohesin isoforms to genome architecture, we carried
out Hi-C experiments in MCF10A cells depleted from SA1 or SA2 by siRNA. In order to avoid
the effect of cell cycle on possible differences in the interaction profiles, we enriched the cell
populations  in  G1  by  growing  cells  at  high  confluency  to  arrest  cell  cycle  by  contact
inhibition. Depletion levels estimated by immunoblot  were similarly high for SA1 and SA2
(Figure R25a) and between 70 and 80% of the cells were in G1 (Figure R25b).
Figure R25. Cells depleted from SA1 or SA2 by RNAi and enriched in G1 for Hi-C analyses 
a. Immunoblot analysis to assay the remaining levels of cohesin 72h after transfection of the
indicated siRNAs. Tubulin is used as loading control. 
b. Cell cycle profiles of MCF10A proliferating cells and of each of the samples used for Hi-C
analysis. Percentages of cells in each phase are indicated.
We generated two libraries per condition from two replicates for each biotin and sequenced
around 250 million read pairs per replicate. Data analyses were carried out by Marc Marti
Renom at CNAG-CRG and details are given in the Methods section. Details on sequencing
of the HiC experiment are summarized in Table 5 of the ANNEX.
Normalized Hi-C contact maps for all chromosomes were generated at 100Kb resolution for
each replicate (Figure 26a). They showed high correlation between replicates and the same
was true for  Eigen values (Figure R26b and R26c).  For  analysis  described below, only
results obtained merging reads from both replicates of each condition are shown, but in all
cases individual replicates were also analysed. 
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Figure R26. Hi-C analyses of MCF10A cells with reduced levels of SA1 or SA2
a. Hi-C  normalized  interaction  maps  for  chromosome  15  at  100Kb  resolution  for  the  two
replicates (r1 and r2) for each condition siC, siSA and siSA2. 
b. Correlation between replicates of each condition of all data in the normalized interaction map
for chromosome 15
c. Correlation between the Eigen values.
4.1. Role of cohesin variants on TAD and compartment  conservation
We  first  examined  whether  depletion  of  SA1  or  SA2  affected  the  identity  of  active
euchromatic (A) and repressive heterochromatic (B) compartments. Visual inspection of the
Eigen values from which the analysis of compartments is done for individual chromosomes
shows no clear alterations in compartmentalization (Figure R27a).  Genome wide,  only a
small percentage of bins changed from A to B, or vice versa (Figure R27b). In other words,
the identity of compartments was largely unperturbed with depletion of SA1 or SA2. 
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Figure R27. No change in compartment identity in the absence of SA1 or SA2
a. First  eigenvector  for  chromosome  13  at  100Kb  resolution.  A  compartment,  red;  B
compartment, blue. 
b. Scatter  plot  of  eigenvectors  (EV)  of  the  intra-chromosomal  interaction  matrices  indicated.
Numbers within the plot show the % of bins that change compartment.
Then we asked to which extent depletion of one or the other cohesin variant affected overall
segmentation  of  genome into  topologically  associated domains  or  TADs.  At  first  glance,
contact maps for the three conditions appear to be similar (Figure R28). However, a more
detailed analyses revealed some differences. 
Figure R28. Contact maps for MCF10A cells depleted for cohesin variants
Vanilla normalized Hi-C matrices for chr13 at 100Kb resolution in mock transfected (siC), SA1
depleted (siSA1) and SA2 depleted (siSA2) cells
Depletion of SA1 increased the number of TADs by 204, whereas depletion of SA2 led to a
decrease of 439 TADs, when compared to control condition (Figure R29a). Furthermore, we
detected minor changes in TAD border strength in both siSA1 and siSA2 conditions, which
was  slightly  more  pronounced  for  the  SA1  depletion  (Figure  29b).  This  finding  was
consistent with our previous results hinting to joint activity of cohesin-SA1 and CTCF at TAD
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borders. Interestingly, TAD border conservation was diminished by 25% after SA2 depletion
while no significant reduction was caused by depletion of SA1 (Figure R29c). We therefore
suggest that some TADs might arise in a CTCF independent manner and instead depend on
the interaction of intra-TAD cohesin-SA2 with different transcriptional regulators. 
Figure R29. TAD border conservation is reduced when SA2 levels are reduced 
Boxplots showing number of TADs per chromosome (a), TAD border strength (b) and TAD border
conservation  (c). A border  was considered conserved between siControl  (siC)  and siSA1 or
siSA2 experiments if it was localized within +/- 2 two bins in both experiments. The box extends
from the lower to upper quartile values of the data, with a line at the median. Notches represent
the confidence interval around the median.
4.2. Cohesins SA1 and SA2 are involved in different types of chromatin interactions
In  view of  their  different  genomic distribution and enrichment  in  functional  elements,  we
wondered if cohesin-SA1 and cohesin-SA2 could have specific roles in the establishment of
distinct types of chromatin interactions involved in different biological processes. Indeed, the
analysis  of  the genomic interactions as a function of  the genomic distance evidenced a
distinct behaviour for SA1 and SA2 depleted cells compared to control cells. Loss of SA2
increased mid-range contacts (0.1 -1.3 Mb, blue shade in Figure R30) while loss of cohesin-
SA1 increased long-range contacts (>1.4 Mb, red shade in Figure R30). 
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Figure  R30.  Decay  of  genomic  interactions  as  a  function  of  distance  differs  upon
downregulation of SA1 or SA2
Interaction decay plot  showing Hi-C interactions as a function of  genomic distance averaged
across the genome for a maximum distance of 50 Mb for siSA1 (red line) and siSA2 (Blue line)
treated cells compared to mock treated cells. Shadowed areas highlight intervals in which clear
differences are found between conditions.
These distinct effects were also evident in matrices representing gained and lost interactions
separately.  Gain  of  long-range  interactions  for  siSA1  condition  was  observed  as  signal
enrichment  far  from  the  diagonal,  at  distance  lengths  of  several  megabases,  while
interactions decreased close to the matrix diagonal (Figure R31a, upper panels). In contrast,
interactions increased in the mid-range (500kb-2Mb range) in the SA2 depleted cells, not so
far from the diagonal while loss of interactions occurred at very short distances, very close to
the diagonal (Figure R31a, lower panels). 
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Figure R31. Distinct effect of SA1 and SA2 depletion on long range chromatin contacts
a. Increased  (red)  and  decreased  (blue)  genome-wide interactions  between  siSA1 or  siSA2
treated cells compared to control cells in chr15.
b. Boxplots  showing  differential  interactions  (averaged  per  chromosome)  separating  them
according to their  being inter-  or  intra-TAD interactions and to their  localization in A or  B
compartment.
When we analysed the localization of lost and gained interactions with respect to A and B
compartments, we found that the increased interactions SA1 depleted cells were located
within  the B compartment,  while  mid-range interactions  were lost  in  the  A compartment
(Figure 31b). Moreover, both gained and lost interactions could be inter- or intra-TAD, with
no obvious bias. One possible interpretation of these data is that SA1 depletion results in a
more "relaxed" A compartment,  which is compensated by increased compaction of the B
compartment. 
In contrast, increased mid-range contacts observed upon SA2 depletion were inter-TAD and
mostly within the A compartment, at least in part due to loss of TAD borders. Decreased
short-range contacts were intra-TAD, within A and B compartments, that could correspond to
enhancer-enhancer  or  enhancer-promoter  interactions,  given the prevalence of  SA2-only
positions in these elements. 
In spite of the limitations of the resolution of our Hi-C experiments, and aimed to establish a
correlation  between  cohesin  genomic  distribution,  gene  expression  and  chromosomal
organization, we examined the enrichment of several features including TSS, RNA (as a
measure of gene expression), cohesin and CTCF positions in A and B compartments, A/B
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borders  and  TAD  borders.  As  expected,  all  the  mentioned  features  were  found  to  be
enriched  more  than  expected  at  A compartments,  with  SA2-only  positions  being  more
enriched  than  common  and  SA1-only  positions.  At  TAD  borders,  SA1-only  and  CTCF
positions were more enriched than SA2-only positions. Most features were depleted from
borders separating A and B compartments as well as from B compartments, except SA1-only
positions. This finding suggested that cohesin-SA1 might play a unique role in modulating
A/B compartment identity, although, as shown above, no clear compartment switches were
found in siSA1 treated cells.
Figure R32. Correlation between cohesin distribution and genome organization
Enrichment of SA1-only, SA2-only and common cohesin sites in AB compartments, A/B borders
and TAD borders. CTCF, TSS and RNA (from RNA-seq data) are included as well. Squares with
numbers are significant (Fisher exact test, p-values < 0.001).
In  summary,  we  propose  that  cohesin-SA1  has  a  more  structural  role  in  genome
organization,  in  particular  mediating  TAD/subTAD  formation  together  with  CTCF,  while
cohesin-SA2  would  be  more  important  for  functional  intra-TAD  contacts  together  with
transcriptional regulators. In the absence of cohesin-SA1, cohesin-SA2 can still cooperate
with  CTCF  in  genome  organization  although  border  strength  is  decreased  and  the  A
compartment is loosened. In the absence of cohesin-SA2, short-range intra-TAD contacts
decrease while new contacts are formed between neighbouring TADs and these changes
have more noticeable consequences for gene expression.
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Due to its role in sister chromatid cohesion, cohesin is essential for genome stability and
inheritance. In addition, its capacity to hold topologically two DNA segments and bring them
into close proximity transcends the mitotic context and is instrumental for mediating folding
of  the  chromatin  fibre  in  interphase  cells.  The  resulting  3D  structure  is  dynamic  and
contributes to genome function. 
All four subunits of cohesin are indispensable for the complex to be functional. Two distinct
cohesin complexes that  carry  one of  two isoforms of  the  SA subunit  coexist  in  somatic
vertebrate cells. The fact that these isoforms share high sequence identity could explain why
the  existence  of  two  cohesin  variants  has  long  been  neglected  in  functional  studies.
However, a few studies have recently pointed to non-redundant activities of the two isoforms
in  cohesion  and  embryonic  development.  Cohesin-SA1and  cohesin-SA2  are  specifically
required  for  telomere  and  centromere  cohesion,  respectively  (Remeseiro  et  al.,  2012a;
Canudas  and  Smith,  2009). Importantly,  the  presence  of  both  cohesin  variants  is
indispensable for proper embryonic development since mouse deficient for SA1 or SA2 are
embryonic lethal (Remeseiro et al., 2012a; M. De Koninck and E. Lapi, unpublished results).
In this thesis, we have explored the functional specificities of the two cohesin complexes
regarding their  contribution  to 3D chromatin organization  and gene regulation.  We have
observed consistent differences in their genome-wide distribution, especially with respect to
colocalization with CTCF, and their enrichment in functional genomic elements. Consistent
with this finding, depletion of either isoform has different impact on gene expression, pointing
to  distinct  mechanisms  of  gene  regulation  by  cohesin-SA1  and  cohesin-SA2.  We  also
provide strong evidence that the two complexes contribute differently to the organization of
the  genome  at  the  megabase  scale  by  mediating  different  ranges  of  "in  cis" genome
interactions.  While  cohesin-SA1  preferentially  contributes  to  the  stabilization  of  TAD
boundaries together with CTCF, cohesin-SA2 promotes local contacts between enhancers
and  promoters  together  with  transcriptional  regulators.  Importantly,  cohesin-SA1  cannot
perform this function when SA2 is absent.
1. The different distribution and dynamic behaviour of cohesin-SA1 and 
cohesin-SA2 
We have identified three categories of cohesin positions that are conserved in all the human 
cell lines that we have examined: common, SA1-only and SA2-only. Results from our group 
not shown in this Thesis confirm that they are also found in mouse ES cells and MEFs. 
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1.1 Common cohesin positions
Both  cohesin-SA1  and  cohesin-SA2  can  be  found  at  common  positions,  which  always
overlap with CTCF. Although an important fraction of these positions can be found in cis-
regulatory elements, a larger fraction occupies a chromatin state defined by the presence of
CTCF. These positions have higher cohesin occupancy and are therefore easier to detect. 
Since ChIP analyses are performed in a cell  population, it  is unclear whether at each of
these positions there is more than one cohesin complex. It is conceivable that one cell would
have cohesin-SA1 while its neighbour would have cohesin-SA2 at a given position at the
time  of  fixation,  resulting  in  detection  of  the  two  complexes  at  that  genomic  location.
However, our Re-ChIP analyses indicate that, at least in several common positions, more
than one complex is indeed present. One can imagine two configurations for this situation,
one with two complexes co-entrapping the two segments at the base of a loop and another
with two interacting complexes each embracing a segment (“stacking”  and “handcuffed”,
respectively, in Figure D1a).  As described in the Introduction, it is likely that cohesin arrives
at these CTCF-bound sites through loop extrusion after being loaded elsewhere (Busslinger
et  al.,  2017).  The  presence  of  CTCF proteins  could  represent  an  obstacle  for  cohesin
progression, either physical, as suggested by in vitro data (Stigler et al., 2016; Davidson et
al., 2016), or functional. Recent data support the idea that Pds5 is required for cohesin to
arrest at CTCF sites (Wutz et al., 2017) and it has been suggested that these sites would
favour the replacement of NIPBL -which is required for loop extrusion- by Pds5 (Petela et al.,
2017; Haarhuis et al., 2017). 
Figure D1. Cohesin configuration at common positions 
See text for details.
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Single-molecule imaging approaches have reckoned  that CTCF binds chromatin much more
dynamically than cohesin, ~1 min vs. ~22 min residence time (Hansen et al., 2018). Indeed,
binding of CTCF and cohesin to chromatin is very different. CTCF establishes non covalent
interactions with specific DNA sequences through its zinc finger domains (Hashimoto et al.,
2017) while cohesin has to be loaded topologically (Haering et al., 2008) and it is still unclear
where the chromatin fiber is located inside the ring and what kind of interactions the different
subunits establish with the DNA. In any case, it  seems likely that once a loop has been
formed, cohesin stays in place even if CTCF dissociates and rebinds, at least for several
minutes. The sharp and narrow profiles of average density plots at common sites agree with
the idea of CTCF being the major determinant of cohesin positioning. Both SA1 and SA2
show the same behavior at these sites, suggesting that they both are stopped by CTCF in a
similar  way. Alternatively, cohesin-SA1 may be more easily stopped by CTCF and, once
there, it may retain cohesin-SA2 complexes arriving afterwards (Figure D1b). This idea is in
fact consistent with the observed redistribution of cohesin-SA2 in SA1-deficient MEFs, which
results in detection of two times more cohesin binding sites compared to wild type MEFs.
The new sites are  featured by  low cohesin  occupancy and lack  of  CTCF colocalization
(Remeseiro et al., 2012b). Thus, cohesin-SA2 can still occupy common positions on its own
when SA1 is depleted, but may be stopped at these positions for shorter times. To test this
hypothesis,  it  would  be  interesting  to  repeat  the  imaging  experiments  described  above
(Hansen et al.,  2018) for SA1 and SA2-containing complexes in wild type cells and cells
lacking either SA1 or SA2.
Why would be cohesin-SA1 retained preferentially at CTCF sites? We can entertain several
possibilities. For instance, in vitro studies showing recombinant cohesin complexes moving
along  naked  DNA,  mentioned  above,  suggest  that  DNA-bound  cohesin  adopts  a
conformation in which the size of the pore is relatively small,  thus hindering its ability to
bypass DNA-bound proteins such as CTCF (Stigler  et  al.,  2016,  Davidson et  al.,  2016).
Similar studies comparing the two cohesin variants could elucidate whether the two cohesin
variants assume different conformations when bound to DNA and determine their ability to
bypass different obstacles. Alternatively, if cohesin’s arrest at CTCF sites depends on the
replacement of NIPBL by Pds5, the switch could be easier for cohesin-SA1 than cohesin-
SA2. While both SA1 and SA2 containing complexes can associate with cohesin regulators
(Pds5A/B, WAPL, Sororin), immunoprecipitation analyses suggest that the affinity for these
interactors  could  be  different  (Kim  et  al.,  2016).  In  our  study,  for  instance,  SA2
immunoprecipitates pull down more WAPL.   
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The two variants could also have different affinities for CTCF. Only one study has dissected
the interaction between CTCF and cohesin biochemically (Xiao et al.,  2011). In vitro pull
down experiments indicated that  a fragment of  SA2 comprising amino acids 162 to 290
could interact with CTCF. Interestingly, residues next to this region (K290, D326 and K330
are key for binding to WAPL, cohesin unloading factor (Hara et al., 2014). Thus, there could
be some competitive binding of WAPL and CTCF to the SA subunit, and the balance could
be slightly different  for SA1 and SA2, even though both proteins are highly homologous
along these regions.  Our data indicate that the ratio between cohesin and WAPL is much
lower in common than in SA2-only positions, again suggesting that the presence of CTCF
impairs  WAPL accessibility  and  as  a  consequence,  stabilizes  cohesin  binding  at  CTCF
positions (Figure D2).  
Figure D2. Different determinants of cohesin binding to chromatin
Binding of cohesin at common positions is determined by CTCF while binding of cohesin at SA2-
only positions may depend on the presence of transcriptional regulators located at enhancers.
The presence of CTCF or the observed stacking of cohesin rings at common positions could
restrict WAPL accessibility. 
The calibrated ChIP-seq experiment that we performed in MCF10A cells depleted of SA1 or
SA2  has  also  shown  that  removal  of  any  of  the  cohesin  variants  leads  to  increased
accumulation of  the other variant  at  common positions. This could reflect  the attempt to
compensate and ameliorate possible structural problems related with the function of cohesin
complex at those sites. Intriguingly, we did not observe changes in chromatin bound levels of
cohesin variants under those conditions, as measured by immunoblot. Thus, we speculate
that the observed increase could be due to the redistribution of the remaining cohesin variant
from “background” locations. It is also unclear whether this increase fully restores the levels
of  cohesin  in  control  condition  –  a  calibrated ChIP-seq  analyses  of  a  common cohesin
subunit such as SMC1 should be performed to answer this question- or if both variants have
the same ability to form TAD boundaries together with CTCF in common sites.  As discussed
90
Discussion
in  the  last  section,  this  may  not  be  the  case,  since  SA1  depletion  affects  TAD border
strength. 
1.2 SA2-only cohesin positions
SA2-only positions are clearly different from common positions. They lack SA1 and CTCF,
are mainly located in enhancers, have lower cohesin occupancy and are more difficult to
detect.  The  existence  of  CTCF-independent  cohesin  positions  had  been  previously
described in human and murine cells (Schmidt et al., 2010; Kagey et al., 2010). Our work
demonstrates that cohesin-SA2 is the variant present at these sites. Schmidt et al. (2010)
identified a fraction of cohesin in human breast and liver cancer cells that did not localize
with  CTCF  but  with  the  estrogen  receptor  (ER)  and  liver-specific  transcription  factors,
respectively. They concluded that “cohesin co-binds across the genome with transcription
factors independently of CTCF (…) and may help to mediate tissue-specific transcriptional
responses via  long-range chromosomal interactions”.  Later  on,  the same group mapped
cohesin, CTCF, and a collection of tissue-specific and ubiquitous transcriptional regulators
using  ChIP-seq  in  primary  mouse  liver  and  confirmed  that  cohesin  sites  lacking  CTCF
correlated instead with  the binding  of  master  regulators  and  enhancer  marks  and  were
significantly associated with liver-specific expressed genes (Faure et al., 2012). Interestingly,
three different cohesin subunits were immuno-precipitated from chromatin, Rad21, SA1 and
SA2. Although the authors decided to define cohesin presence as the occurrence of at least
one of  its  subunits,  the  prevalence of  SA2 over  SA1 in  these so called  “cis-regulatory”
modules was clear (Figure D3). 
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Figure D3. Cohesin-SA2 is the variant present at cohesin-non CTCF sites  
Results from the study by Faure et al. (2012). Top, Results from K-means clustering (K = 10) of
the binary presence/absence of ChIP-seq peaks of the indicated transcription factors within cis-
regulatory modules (CRMs) in mouse liver cells. The clusters were indexed and sorted by the
proportion of CRMs with cohesin-non-CTCF peaks in each cluster (increasing from left to right).
Bottom, the binary presence/absence of ChIP-seq peaks for cohesin and the indicated chromatin
features visualized according to the K-means results as above. We have overlay squares show-
ing common and SA2-only cohesin positions.
Average read density plots of SA2-only positions are broader, which could indicate that the
way cohesin arrives and stops at these positions is different from the one described above
for common positions. Kagey et al. (2010) first showed the presence of cohesin connecting
the  enhancers  and  promoters  of  pluripotency  genes  in  mouse  ES  cells  together  with
Mediator in order to maintain active transcription. NIPBL was found at the same sites and
was shown to interact physically with cohesin and Mediator, suggesting that cohesin loading
could occur directly at these sites. In such scenario, one could envision cohesin stabilizing
an enhancer-promoter loop already established by Mediator, transcription factors and RNA
polymerase II. The exact position of the loaded cohesin complex could be less fixed and
thereby give rise to the broader average profiles observed (Figure D4).
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Figure D4. The exact position of cohesin-SA2 at enhancer-promoter loops is variable
Unlike common positions, in which the binding of CTCF fixes the positions of the coheisn
complex, the precise position of cohesin-SA2 at enhancer promoter loops could be slightly
different in cells in the population. We suspect that arrest of cohesin could  also be shorter.
Why  is  cohesin-SA2  the  preferred  variant  in  these  local  chromatin  loops  involving
transcriptional  regulators?  One  possibility  is  that,  as  discussed  above,  cohesin-SA1
becomes more easily retained at CTCF positions leaving less soluble cohesin-SA1 complex
available for NIPBL to load at these sites. Another is that NIPBL may have higher affinity for
cohesin-SA2. In vitro, the SA subunit is essential for cohesin loading although its function in
the process remains unclear (Murayama et al., 2014). Recent studies report that SA1 and
SA2 can bind double stranded (ds) and single stranded (ss) DNA, with a preference for the
latter that is more clear in the case of SA2 (Lin et al., 2016; Countryman et al., 2018). In one
of  these studies,  the SA2 protein was shown to switch between a diffusion mode along
dsDNA to stable binding at ssDNA gap. Whether SA1 can do the same was not investigated.
Interestingly, an in vitro reaction that recapitulates establishment of DNA-DNA interactions by
a cohesin ring already embracing dsDNA has  shown that the second DNA molecule must be
ssDNA (Murayama et al., 2018). Taken all these evidences together, we speculate that initial
binding of cohesin to DNA before topological entrapment likely depends on the SA subunit
and each variant may display different specificities regarding secondary structures of the
DNA or the presence of single stranded nucleic acids (DNA or even RNA) resulting from
active transcription. Finally, protein-protein interactions with transcriptional regulators present
at  enhancers  could  also  drive  preferential  loading  of  cohesin-SA2  at  these  sites.  The
homology between SA1 and SA2 decreases in the N- and C-terminal regions (see Figure I10
of  Introduction),  and  such  regions  could  be  responsible  for  binding  specific  interactors.
Indeed, N-terminus of SA1 interacts with telomeric protein TRF1, which enables cohesin-
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SA1 to  mediate  telomeric  cohesion  (Canudas  et  al.,  2007;  Canudas  and  Smith,  2009).
Similarly, SA2 may interact with certain transcriptional regulators through its unique regions.
1.3 SA1-only cohesin positions
SA1-only sites have significantly higher enrichment of SA1 than SA2 and co-localize with
CTCF. At least in HMEC cells, almost half of the SA1-only sites are located in chromatin
states  corresponding  to  “heterochromatin/low  signal”  regions  that  could  correspond  to
regions with low accessibility to the antibodies used for ChIP-seq. The presence of  some
SA2 and CTCF makes us think that these could be in fact a subset of common positions in
which detection of SA2 is less efficient than detection of SA1 (Figure D5). However, we
cannot  rule out that SA1-only sites could be specialized cohesin positions with a unique
structural function, different from that of common positions. Supporting this last hypothesis is
the  finding  that  SA1-only  regions  are  enriched  in  the  transitions  between  A  and  B
compartments  (Figure  R32).  Also,  unlike  common  positions,  cohesin-SA1  sites  are  not
conserved between cell types. What is clear from our results is that the function of cohesin-
SA1 is tightly linked to CTCF. 
Figure D5. SA1-only cohesin positions
Snapshot of the genome browser showing examples of SA1-only positions. Distribution of CTCF,
SA1, SA2 and SMC1 from  HMEC is  shown. SA1-only positions are shown next to common
cohesin positions in b and c. 
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2. Cohesin-SA2 regulates cell-type specific gene expression
The analysis of cohesin variants enrichment in different chromatin states has strengthened
our hypothesis about  their different functions. The high association of SA2-only positions
with enhancers, in particular superenhancers, and with gene promoters, has corroborated
previous findings showing enrichment of CTCF-less cohesin positions in regulatory elements
(Kagey et al., 2010; Schmidt et al., 2010; Faure et al., 2012; Figure D3). On the other hand,
the observed association of common and SA1-only positions with insulators was expected,
given the almost complete overlap of these positions with CTCF. It is important to highlight
that SA1-only positions, even when their number differed between the cell lines in the study,
behaved  similar  to  common  positions,  with  the  exception  of  their  enrichment  in
heterochromatic/poorly  defined  regions,  whose  relevance  is  still  an  open  question  as
discussed above. 
We were  interested  in  identifying  potential  SA2-specific  DNA-binding  factors  that  would
account  for  its  particular  genomic  distribution.  Both  our  motif  enrichment  and  proteomic
analysis strongly indicate that cohesin-SA2 could fulfil gene regulatory functions in a CTCF-
independent manner through its association with different factors. Moreover, transcriptional
regulators such as ZMYM2 and YAP1 were found to interact specifically with cohesin-SA2
and we showed that they bound at cohesin SA2-only sites. One important limitation of the
immunoprecipitations analysis is the difficulty of preserving cohesin interactions that occur in
the  context  of  3D  folded  chromatin.  The  use  of  detergents,  nucleases  or  sonication  to
release cohesin  from chromatin  will  necessary  disrupt  chromatin  topology and therefore
impede protein-protein interactions that occur in a particular chromatin conformation. In fact,
we were not able to get CTCF in our proteomic analysis. Similarly, we did not find ZMYM2
and YAP1 binding motifs  in  the  motif  enrichment  analysis  of  SA2-only  positions.  In  this
regard, it is worth mentioning a study proposing that cohesin would stabilize the binding of
transcription factors to lower-affinity sequence motifs (Faure et al.,  2012).  In addition, the
ways in which cohesin interacts with transcription factors are still largely unknown. 
Recent work from our group has supported the hypothesis that CTCF-less cohesin positions
are involved in cell-type specific gene regulation (Cuadrado et al., 2015). In this study, the
genome-wide  distribution  of  cohesin  in  two  murine  tissues,  brain  and  pancreas,  was
explored and correlated with their  tissue-specific  expression programmes.  Several  major
conclusions from this study were important for this thesis: 1) CTCF-bound cohesin sites are
more invariant  between tissues than cohesin  non-CTCF sites;  2)  tissue-specific  cohesin
positions display better overlap with marks of active enhancers and promoters (H3K4Me1
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and H3K4Me3) than common cohesin sites 3)  tissue-specific  cohesin is  more frequently
found at active tissue-specific genes than tissue-specific CTCF (Figure D6). In that study,
ChIP-seq was performed using SMC1 and SA1 antibodies, but no SA2, so we can only
indirectly infer which cohesin positions correspond to each variant. The fact that that many
active CTCF-less promoters contain SMC1 with no or little SA1 support the existence of
SA2-only positions at those active promoters. On the other hand, active promoters that were
bound by both cohesin and CTCF displayed similar frequency of both SMC1 and SA1. 
Figure D6. Cohesin distribution correlates with tissue-specific transcription
Heat-map visualization of the pairwise overlap between cerebral cortex chromatin marks and cor-
tex-specific and non-specific (‘common’) SMC1 and CTCF positions.  Cortex-specific cohesin
(SMC1) binding sites display a better overlap with enhancer and promoter marks (H3K4Me1 and
H3K4Me3) than ubiquitous cohesin binding sites (purple rectangle). This is not the case when
comparing the overlap of cortex-specific and common CTCF positions with those same chro-
matin marks (blue rectangle). Moreover, cortex-specific cohesin is more frequently found at the
promoters of cortex specific genes than cortex-specific CTCF (compare green and yellow rectan-
gles). Taken from Cuadrado et al., 2015. 
Based on these previous results, we explored the cell-type specificity of cohesin variants
distribution between the two human primary cell lines from different embryonic origin used in
our study, HMEC and HCAEC. While common positions were highly conserved, SA2-only
positions were mostly cell-type specific. This result, together with the enrichment of SA2-only
sites  in  superenhancers  points  to  a  critical  role  of  cohesin  SA2  in  the  control  of  the
transcriptional programs that define cell identity (Hnisz et al., 2013). It was surprising to find
that, in spite of showing clear similarities to common positions, SA1-only positions are cell-
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type specific,  which reinforces the above discussed possibility that  these positions could
have a different and still unexplored role.
Transcriptome  analyses  after  depletion  of  the  two  cohesin  variants  have  shown  that
reduction of cohesin-SA2 levels alters the expression of about 700 genes in MCF10A cells,
while depletion of cohesin-SA1 affects the expression of a little over 150 genes. The small
overlap between the genes whose transcription changes in SA2 and CTCF depleted cells
further  confirmed  a  CTCF-independent  function  of  cohesin-SA2.  In  hematopoietic
precursors, knock down of SMC1 or SA2 led to similar gene deregulation driving premature
commitment to the myeloid lineage (Mullenders et al., 2015), consistent with a more clear
role  of  cohesin-SA2  in  gene  regulation.  On  the  other  hand,  the  modest  effect  of  SA1
depletion on gene expression may be due to the fact that, under this condition, the function
of  cohesin-CTCF  exerted  common  positions  can  be  performed  by  cohesin-SA2.  This
function is likely related with the maintenance of TAD boundaries and might have little impact
on overall transcription. In fact, even when most cohesin is removed, the consequences on
gene regulation are not that compelling. For instance, genetic deletion of the cohesin loader
NIPBL from mouse liver cells reduced significantly cohesin levels and disrupted TAD integrity
but led to modest changes of gene expression affecting around 1,000 genes (Schwarzer et
al.,  2017).  The  authors  showed  that  observed  changes  were  likely  due  to  impaired
communication  of  regulatory  elements  with  target  genes,  even  though  the  regulatory
capacity of the enhancers was preserved. Acute removal of cohesin in human HCT116  cells
using  a degron system combined with measurement of nascent transcription by PRO-seq
revealed that only genes linked to superenhancers were strongly downregulated whereas
most other genes were mildly affected (Rao et al., 2017). Although these results seem to
argue against a major role of cohesin in facilitating enhancer-promoter communication, we
should bear in mind that small changes in transcription of key genes may be physiologically
relevant in specific cell contexts, such as a cancer cell (Flavahan et al., 2016; Shen et al.,
2016),  or  when the cell  needs to respond to developmental cues, hormone signalling or
other environmental stimuli (Stadhouders et al.,  2018; Le Dily et al.,  2014; Antony et al.,
2015;  Xu et al., 2016). Zuin et al. (2014) first showed that depletion of CTCF or depletion of
cohesin (RAD21) altered the expression of distinct groups of genes. We found that only one
third of the genes deregulated in siSA2 treated cells were also deregulated upon depletion of
CTCF in MCF10A cells. Reduction of CTCF levels caused deregulation of a larger number of
genes (1191 in siCTCF vs 716 in siSA2 treated cells).  A recent study reported changes in
around 5,000 genes upon acute, near complete removal of CTCF by a degron system in
mouse ES cells (Nora et al., 2017). However, it is important to note that the number of genes
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showing altered expression 1 day after inducing cohesin degradation were only 370, 13-fold
less  than  at  day  4.  Thus,  secondary  effects  can rapidly  become confounding  making  it
difficult to asign the cause of a transcriptional change to a change in chromatin contacts. The
use of degrons has proven in the last years to be a very efficient and reversible system to
eliminate a protein in an acute way (Nishimura et al., 2009; Natsume et al., 2016; Nora et al.,
2017;  Rao et  al.,  2017;  Wutz  et  al.,  2017).  This  methodology  overcomes the problems
related with incomplete depletion obtained by other techniques such as siRNA transfection
and  are  particularly  suited  for  stable  proteins  like  cohesin.  We plan  to  develop  degron
systems to deplete each of the cohesin variants in the near future, in order to further improve
the study of SA1 and SA2 specific functions. 
Apart from the magnitude of the transcriptional changes, we were interested in their entity.
The significant  up-regulation of  pathways specific  for  hematopoietic  and nervous system
together with the aberrant  expression of  several  important  cell-type specific  transcription
factors observed in MCF10A cells with reduced levels of SA2 (e.g., of Irx3 and Tfap2c or
BDNF) agrees with the role of cohesin-SA2 in maintaining cell identity (Figure D7). 
Figure D7. Cohesin-SA2 is responsible for maintaining cell identity
SA2-only cohesin positions are largely cell-type specific and enriched in cell-type specific super-
enhancers. Cohesin-SA2 regulates expression of cell-identity genes from SA2-only positions in
a CTCF-independent manner, through interaction with different TFs (left). Absence of cohesin-
SA2 leads to dysregulation of cell-identity genes (right).
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Such role is  also  consistent  with the hypothesis  that  loss  of  function cohesin mutations
identified  in  myeloid  malignancies  are  associated  with  skewing  of  expression  programs
towards  precursor  cells  and  their  impaired  differentiation  potential,  as  mentioned  above
(Mazumdar  et  al.,  2015;  Mullenders  et  al.,  2015;  Viny  et  al.,  2015).  It  has  also  been
suggested that cohesin works together with Polycomb-group proteins in these hematopoietic
precursors to repress  Hox genes (Fisher et al., 2017; Li et al., 2017). Unpublished results
from our group indicate that cohesin-SA2 is the major cohesin variant present at Polycomb-
bound regions in mouse ES cells. These results support the promiscuous role of SA2 in the
control  of  gene  expression,  being  involved  both  in  activation  and  repression  of  gene
transcription, likely through its ability to associate with transcriptional regulators.
Finally, by analysing the S100 gene cluster in different cell lines, we have observed a strong
correlation between the presence of SA2-only positions, the intensity of local interactions
and the levels of expression of nearby genes. Moreover, several genes of the cluster that
contain  cohesin-SA2  only  positions  at  their  promoters  in  MCF10A  cells  become
downregulated after reduction of SA2 levels. This findings support the idea that the presence
of  cohesin-SA2 plays an important  role for  the establishment and/or maintenance of  the
physiological  regulatory  contacts  between  genes  and  their  corresponding  regulatory
elements.
3. Cohesin variants make different contributions to genome organization
The  emergence  of  3C  techniques,  especially  Hi-C,  revolutionized  our  understanding  of
genome organization (Dekker et al. 2002; Lieberman-Aiden et al. 2009; Dixon 2012; Nora
2012). Current opinion in the field holds that cohesin-mediated loop extrusion within defined
genomic regions is a plausible mechanism of genome organization at the megabase scale
(Sanborn  et  al.,  2015;  Fudenberg  et  al.,  2016).  Consistent  with  this  idea,  TADs  and
prominent  Hi-C  loops  largely  disappear  when  cohesin  or  CTCF  are  strongly  depleted
(Gassler et al., 2017; Nora et al., 2017; Rao et al., 2017; Wutz et al., 2017; Schwarzer et al.,
2017).
Efficient removal of CTCF leads to disappearance of TADs and loops formed between two
CTCF sites since cohesin no longer encounters loop delimiting factors (Figure D8, top left).
However, overall scaling of Hi-C contact frequency as a function of genomic distance is not
disturbed, meaning that CTCF does not affect general chromatin compaction (Nora et al.,
2017; Wutz et al., 2017; Figure D8, top right). On the other hand, efficient removal of cohesin
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from chromatin  leads to  diminishment  of  TADs and  loops  accompanied  by  a  significant
reduction  of  contact  probabilities  at  scale  of  10-100s  of  kilobases  that  corresponds
compaction of genome at a megabase scale (Schwarzer et al., 2017; Figure D8, bottom).
Figure D8. Cohesin and CTCF are required for loop and TAD formation 
Hi-C maps for the indicated region in chromosome 5 in mouse ES and liver cells before and after
depletion of CTCF (top) and the cohesin loader NIPBL (bottom), replotted from Nora et al, 2017,
in which an auxin-inducible degron system was used to deplete CTCF in mESCs and Schwarzer
et  al.  2017 who used CRE-inducible gene deletion in mouse liver cells to deplete Nipbl and
thereby remove cohesin from chromatin. Right, P(s) for the indicated perturbation compared to
unperturbed P(s) normalized to contact frequency at 10 kb. Adapted from by Fudenberg et al.,
2017.
Even though overall compartmentalization is still present upon removal of CTCF and cohesin
from chromatin, cohesin removal leads to enhanced and finer compartmentalization (Nora et
al.,  2017;  Rao et  al.,  2017;  Schwarzer  et  al.,  2017;  Wutz  et  al.,  2017).  This  enhanced
compartmentalization is reflected in the emergence of smaller, B-like regions within bigger A-
compartments. Additionally, these regions show clear tendency to interact with other regions
of  the  same identity. Interestingly, compartmentalization  profile  of  cohesin-depleted  Hi-C
maps correlated better with the local activity and chromatin state than the profile of wild type
Hi-C maps (Schwarzer et al., 2017). Conversely, compartmentalization is less pronounced in
cells lacking cohesin unloading factor WAPL (Gassler et al.,  2017; Haarhuis et al.,  2017;
Wutz et al., 2017). Thus,  the  intrinsic tendency of chromatin to self-organize based on the
local epigenetic landscape and transcriptional activity is likely counteracted by cohesin loop
extrusion activity, which  brings together  loci  with different  histone modification patterns.
Contrary to the initial idea of compartmentalization being a higher hierarchy over TADs in the
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genome  folding  process,  it  now  seems  that  they  are  two  distinct  modes  of  genome
organization that arise through different mechanisms.
By performing Hi-C analyses in SA1- and SA2-depleted cells, we have demonstrated for the
first time that the two cohesin variants make different contributions to genome organization.
The changes that we observed upon downregulation of one or the other cohesin variant are,
not surprisingly, different from those observed after removal of all cohesin, discussed in the
previous paragraph.  The  amount  of  total  cohesin  left  on  chromatin  in  siSA1 and  siSA2
treated cells is very similar, making unlikely that these changes can be explained by the
abundance of  the  complex.  We have found that  the identity  of  compartments  is  largely
unperturbed  in  both  conditions,  as  expected  from  previous  results  showing  that  near
complete removal of cohesin is necessary to cause mild switches in compartment identity.
TAD border strength showed some decrease upon removal of cohesin-SA1, maybe because
the remaining cohesin-SA2 is sufficient to establish  TAD borders together CTCF but does
not perform this function as well as cohesin-SA1. 
Interestingly, TAD-border conservation was significantly reduced upon removal of cohesin-
SA2.  A recent  study  has  shown that  almost  20% of  TAD borders  are  maintained  after
elimination  of  CTCF implying  that  they  can  be established  by  some CTCF-independent
mechanism (Nora et al., 2017). Moreover, the highest resolution Hi-C maps reported to date
have revealed the existence of three classes of TAD boundaries: (1) bound by CTCF, (2)
lacking CTCF and proximal  to  active promoters,  and (3)  without  CTCF or active marks,
present in repeat containing regions. Cohesin is present in the first two categories (Bonev et
al.,  2017).  Having  in  mind  these  results  and  the  results  shown  in  this  thesis,  we  can
speculate  that  some TAD borders  might  depend  on  the interaction  of  cohesin-SA2 with
different  transcriptional  regulators.  Thus,  removal  of  cohesin-SA2  would  lead  to  their
disappearance. Unfortunately, the 40-kb resolution of our Hi-C analyses was insufficient to
test this hypothesis, since we do not have an accurate map of the TAD borders to correlate
with cohesin-SA2-only  positions. 
Analysis  of  the  genomic  interactions  as  a  function  of  genomic  distance  together  with
inspection of Hi-C matrices displaying differential interaction between each depletion and the
control cells confirmed that the roles of cohesin-SA1 and cohesin-SA2 in genome folding are
not equivalent. Removal of cohesin-SA1 caused an increase in long-range interactions (>
1.4Mb)  and  a  decrease  in  short-  and  mid-range  interactions  (Figure  R31).  Interestingly,
gained interactions  occurred in  the B compartment  while  lost  interactions were in  the A
compartment.  One possible interpretation of these data is that SA1 depletion results in a
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more ‘relaxed’ A compartment,  which is compensated by increased compaction of the B
compartment (Figure D9). The observed situation could be attributed to reduced integrity of
TAD borders when they rely on cohesin-SA2. On the other hand, removal of cohesin-SA2
caused an increase in  mid-range contacts  (0.1  -1.3 Mb)  and a decrease in  short-range
contacts, very close to the diagonal of the Hi-C matrices (Figure R31). It is likely that lost
intra-TAD interactions correspond to enhancer-enhancer and enhancer-promoter contacts
mediated  by  cohesin-SA2.  In  contrast,  the  observed  increase  in  inter-TAD  interactions,
mostly within A compartment, could be in part a consequence of reduced conservation of
non-CTCF  TAD  borders,  and  consequential  emergence  of  new,  inter-TAD  interactions
(Figure D9). A  higher resolution Hi-C experiment would allow us to test dome f these ideas.
We have tried to analyse anchors of lost and gained interactions, but with our resolution we
were not able to pinpoint the correct cohesin positions involved in the interactions. In line
with this,  a  very  recent  study  has shown that  in  the  absence of  cohesin-mediated loop
extrusion new chromatin loops emerge connecting regulatory elements over long distances
(Vian  et  al.,  2018).  Interestingly,  only  half  of  these  loops  have  CTCF at  both  anchors.
Another  explanation  comes  from  the  fact  that  single-cell  Hi-C  experiments  have
demonstrated  a  high  level  of  stochasticity  in  TAD  border  definition  among  cells  in  the
population. These effects are then averaged into population Hi-C maps. Upon depletion of
cohesin-SA2, local contacts could be more disparate among cells in the population making
more difficult TAD definition and thereby decreasing the number of TADs and TAD border
conservation.
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Figure D9. Cohesin variants make different contributions to genome organization
Simplified  model  of  the  role  of  the  coheisn-SA1  and  cohesin-SA2  in  genome  organization.
Cohesin-SA1 mediatesTAD/subTAD formation together with CTCF, while cohesin-SA2 would be
more important for functional intra-TAD contacts together with transcriptional regulators. In the
absence of cohesin-SA1, cohesin-SA2 can still  cooperate with CTCF in genome organization
although border strength is decreased and the A compartment is loosened while the increased
long-range contacts are detected in the B compartment. In the absence of cohesin-SA2, short-
range intra-TAD contacts decrease while new contacts are formed between neighbouring TADs. 
4. Cohesin variants in human disease
The  work  presented  in  this  thesis  brings  us  closer  to  understanding  pathological
consequences of cohesin mutations identified in different cancer types. Given the presence
of cohesin-SA2 at regulatory elements and in particular at super enhancers and the inability
of  cohesin-SA1  to  occupy  such  positions,  we  propose  that  tumour  cells  profit  from
deregulation  of  some key genes in  the  absence of  SA2 to evade proper  differentiation.
Functional studies in the hematopoietic system have indeed shown that  reduced cohesin
activity  promotes  transformation  by  altering  the  balance  between  self-renewal  and
differentiation (Mazumdar et al., 2015; Mullenders et al., 2015; Viny et al., 2015; Fisher et al.,
2017). In these studies, the reduced differentiation potential of hematopoietic precursors is
similar after decrease of total cohesin -by depletion of a common subunit- or decrease of
SA2. We suggest that overall decrease of cohesin may affect more the functions of cohesin-
SA2 due to its more dynamic behaviour. 
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Both cohesin-SA1 and cohesin-SA2 are indispensable for proper embryonic development
(Remeseiro et al., 2012a; M. De Koninck and E. Lapi, unpublished results). However, either
one appears to be sufficient for cell viability. As expected from the essential nature of the
cohesin complex,  a synthetic lethality screen in SA2-deficient cells identified SA1 as the
strongest  candidate  (van  der  Lelij  et  al.,  2017).  Consistent  with  this  result,  a  mutually
exclusive mutation pattern has been observed in tumours between the genes encoding the
two variants, as well as an inverse correlation between their expression levels (Liu et al.,
2018). Importantly, while the loss of both cohesin complexes abrogates cohesion completely
and  leads  to  mitotic  failure  and  eventually  cell  death,  SA1  inactivation  does  not  affect
proliferation of SA2 proficient cells (van der Lelij  et al.,  2017). Thus, it  has already been
suggested that selective inhibition of cohesin-SA1 has big therapeutic potential in treatment
of  the  patients  with  STAG2-mutated  cancers,  under  the  premise  that  it  would  not  be
deleterious for most non-cancerous tissues (Figure D10). Previous work from our group has
shown  that  mice  heterozygous  for  the  STAG1  are  viable  and  fertile  although  display
increased incidence of pancreatic cancer (Remeseiro et al., 2012a). It should be noted that
these animals have reduced dosage of the STAG1 from their conception and the observed
susceptibility to pancreatic cancer could be a consequence of a cumulative effect of aberrant
expression  of  REG  genes  involved  in  proliferation,  differentiation  and  protection  from
inflammation  (Cuadrado  et  al.,  2015).  Even  though  selective  targeting  of  cohesin-SA1
presents a formidable challenge due to high homology between two SA paralogs, we think
that future studies should explore the effects of acute ablation of cohesin-SA1 in adult mice.
Our work in MCF10A cells suggests that the impact of eliminating SA1 is relatively mild in
terms of genome organization and gene regulation.
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Figure D10. Inactivation of cohesin-SA1 for treatment of STAG2 mutant cancers
See text for details.
A recent  study  reports  the  identification  of  STAG1 microdeletions  or  point  mutations  in
children affected by intellectual deficiency and variable associated symptoms (Lehalle et al.,
2017). Heterozygous mutations in STAG2 and duplications involving STAG2 have also been
identified in  female and male patients,  respectively, with symptoms overlapping those of
cohesinopathies (Bonnet et al., 2009; Kumar et al., 2015; Leroy et al., 2016; Philippe et al.,
2013; Yingjun et al., 2015). Gene deregulation is likely at the origin of these pathologies,
although decreased proliferation or reduced ability to deal with DNA damage in the absence
of a full cohesin complement may also contribute. Understanding the role of the two cohesin
variants to genome folding and gene regulation in the context of development is a current
interest of our research.
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1- Cohesin  is  present  throughout  the  genome at  CTCF and  non-CTCF positions.  Both
cohesin-SA1 and cohesin-SA2 are present at CTCF positions (“common”) while  cohesin-
SA2  is  the  predominant  cohesin  variant  at non-CTCF  cohesin  positions  (“SA2-only”).
Common positions are enriched in insulators whereas SA2-only positions localize mainly in
active enhancers.
2- Binding  of  cohesin  to  SA2-only  positions  is  more  dynamic  than  binding  to  common
cohesin  positions.  Cohesin  stacking  at  common  positions,  observed  by  Re-ChIP
experiments,  may hinder the association of  cohesin unloading factor  WAPL and thereby
stabilize cohesin at these binding sites.
3- Cohesin-SA1 cannot be recruited to SA2-only positions in the absence of cohesin-SA2,
thus it cannot assume cohesin functions carried out from them. In contrast, the presence of
cohesin-SA1 and cohesin-SA2 at common positions depends on CTCF but not on the other
variant complex. 
4- Cohesin-SA2 contributes to cell-type specific gene expression in a CTCF-independent
manner from SA2-only positions through association with different transcriptional regulators.
This  activity  of  cohesin-SA2 is  in  part  achieved from cell-type specific  super  enhancers
through regulation of cell-type specific master regulators.
5- Opposite to CTCF, cohesin-SA2 downregulation does not alter overall  topology of the
S100  locus.  However,  there  is  a  strong  correlation  between  the  presence  of  SA2-only
positions, the intensity of local interactions and the levels of expression of nearby genes.
6- Removal  of  a  single  cohesin  variant  does  not  alter  significantly  overall  genome
organization but affects genomic interactions at different distances. Loss of SA2 increases
mid-range (0.1 -1.3 Mb) contacts while loss of SA1 increases long-range (>1.4 Mb) contacts.
7- TAD border strength and TAD border identity depend more on cohesin-SA1 and cohesin-
SA2, respectively.
8- Cohesin-SA1 has a more structural role in genome organization, in particular mediating
TAD/subTAD formation together with CTCF, while  cohesin-SA2 likely facilitates intra-TAD
contacts between enhancers and/or promoters, independently of CTCF and together with
transcriptional regulators. 
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1- El complejo cohesina aparece a lo largo del genoma en posiciones en las que se puede
encontrar o no la proteína CTCF. Tanto cohesina-SA1 como cohesina-SA2 se localizan en
sitios  de  unión  de  CTCF (posiciones  "comunes"),  mientras  que  la  cohesina-SA2  es  la
variante  más  frecuente  en  los  sitios  de  unión  sin  CTCF  (posiciones  "sólo-SA2").  Las
primeras  se  localizan  preferentemente  en  "insulators"  y  las  segundas  se  encuentran
enriquecidas en "enhancers".
2- La unión del complejo cohesina a las posiciones exclusivas de SA2 es más dinámica que
su unión a posiciones comunes. La acumulación de más de un complejo de cohesina en
una posición determinada, observada en experimentos de Re-ChIP, podría dificultar la unión
de  WAPL al  complejo,  evitando  su  disociación  de  la  cromatina,  lo  que  conduciría  a  la
estabilización de la cohesina en estas posiciones.
3- La cohesina-SA1 no puede ocupar sitios "sólo-SA2" en ausencia de SA2, por lo que no
es capaz de desempeñar las funciones asociadas a dichas posiciones. Por el contrario, la
presencia de cohesina-SA1 y cohesina-SA2 en las posiciones comunes depende de CTCF
y no de la presencia de la otra variante del complejo.
4- La cohesina-SA2 contribuye a la expresión génica específica de cada tipo celular. Esta
función depende de su presencia en sitios "sólo-SA2", carentes de CTCF, en los que se
asocia con diferentes reguladores de la transcripción. 
5- La topología general de la cromatina en el locus S100 depende de CTCF pero no de
cohesina-SA2. Existe sin embargo una fuerte correlación entre la presencia de posiciones
exclusivas de SA2, la intensidad de interacciones locales y los niveles de expresión de los
genes adyacentes.
6- La  eliminación  de  una  única  variante  del  complejo  cohesina  no  altera  la  estructura
general  del  genoma  de  modo  significativo.  Sin  embargo,  provoca  cambios  en  las
interacciones genómicas a diferentes distancias: la pérdida de SA2 aumenta los contactos a
distancias medias (de 0.1 a 1.3 megabases), mientras que la pérdida de SA1 aumenta las
interacciones a largas distancias (>1.4 Mb).
7- La fortaleza y la identidad de los bordes de los TADs dependen en mayor medida de
cohesina-SA1 y cohesina-SA2, respectivamente.
8- Mientras que la cohesina-SA1 desempeña mayoritariamente un papel estructural en la
organización del genoma, mediando la formación de TADs y subTADs junto con CTCF, la
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cohesina-SA2 facilita la formación de contactos intra-TAD entre “enhancers” y promotores,
de modo independiente de CTCF y en estrecha relación con distintos reguladores de la
transcripción.
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